제품명 Catalog # 포장단위 중량 Cas No. (7- Diethylaminocoumarin- 4- yl)methyladenosine- 3', 5'- cyclic monophosphate ( DEACM-caged cAMP ) D 042-001 0.1 μmol ~58 μg 339291-37-1 (7- Diethylaminocoumarin- 4- yl)methyladenosine- 3', 5'- cyclic monophosphate ( DEACM-caged cAMP ) D 042-005 5 x 0.1 μmol 339291-37-1 (7- Diethylaminocoumarin- 4- yl)methylguanosine- 3', 5'- cyclic monophosphate ( DEACM-caged cGMP ) D 043-001 0.1 μmol ~63 μg 339291-42-8 (7- Diethylaminocoumarin- 4- yl)methylguanosine- 3', 5'- cyclic monophosphate ( DEACM-caged cGMP ) D 043-005 5 x 0.1 μmol 339291-42-8 (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cAMP ) D 044-001 0.1 μmol ~60 μg pending (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cAMP ) D 044-005 5 x 0.1 μmol pending (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cGMP ) D 045-001 0.1 μmol ~60 μg pending (7- Dimethylaminocoumarin-4- yl)methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( DMACM-caged 8-Br-cGMP ) D 045-005 5 x 0.1 μmol pending [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cAMP ) B 018-001 0.1 μmol ~76 μg 370091-64-8 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cAMP ) B 018-005 5 x 0.1 μmol 370091-64-8 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cGMP ) B 019-001 0.1 μmol ~78 μg 370091-68-2 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cGMP ) B 019-005 5 x 0.1 μmol 370091-68-2 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- guanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cGMP ) B 017-001 0.1 μmol ~69 μg 339291-52-0 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- guanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cGMP ) B 017-005 5 x 0.1 μmol 339291-52-0 1, N6- Ethenoadenine ( ε-Ade ) E 012-10 10 μmol ~1.6 mg 13875-63-3 1, N6- Ethenoadenine ( ε-Ade ) E 012-50 5 x 10 μmol 13875-63-3 1, N6- Ethenoadenosine ( ε-Ado ) E 011-10 10 μmol ~2.9 mg 39007-51-7 1, N6- Ethenoadenosine ( ε-Ado ) E 011-50 5 x 10 μmol 39007-51-7 1, N6- Ethenoadenosine- 3', 5'- cyclic monophosphate ( ε-cAMP ) E 001-10 10 μmol ~3.8 mg 103213-51-0 1, N6- Ethenoadenosine- 3', 5'- cyclic monophosphate ( ε-cAMP ) E 001-50 5 x 10 μmol 103213-51-0 1, N6- Ethenoadenosine- 5'- O- diphosphate ( ε-ADP ) E 007-05 5 μmol ~2.3 mg 103213-52-1 1, N6- Ethenoadenosine- 5'- O- diphosphate ( ε-ADP ) E 007-25 5 x 5 μmol 103213-52-1 1, N6- Ethenoadenosine- 5'- O- diphosphoribose ( e-ADPR ), sodium salt E 013-10 10 μmol ~5.8 mg 69699-76-9 1, N6- Ethenoadenosine- 5'- O- diphosphoribose ( e-ADPR ), sodium salt E 013-50 5 x 10 μmol 69699-76-9 1, N6- Ethenoadenosine- 5'- O- monophosphate ( ε-5'-AMP ) E 005-250 5 x 50 μmol 103213-41-8 1, N6- Ethenoadenosine- 5'- O- monophosphate ( ε-5'-AMP ) E 005-50 50 μmol ~21 mg 103213-41-8 1, N6- Ethenoadenosine- 5'- O- triphosphate ( ε-ATP ) E 004-05 5 μmol ~2.7 mg 60777-99-3 1, N6- Ethenoadenosine- 5'- O- triphosphate ( ε-ATP ) E 004-25 5 x 5 μmol 60777-99-3 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AEA-cAMP ) A 097-05 5 μmol ~1.9 mg 66311-12-4 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AEA-cAMP ) A 097-25 5 x 5 μmol 66311-12-4 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AEA-cAMP-Agarose ) A 110-06 0.6 ml none 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AEA-cAMP-Agarose ) A 110-25 2.5 ml none 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AEA-cAMP-Agarose ) A 110-60 6 ml none 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AEA-cAMPS ) A 093-05 5 μmol ~2 mg pending 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AEA-cAMPS ) A 093-25 5 x 5 μmol pending 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AEA-cAMPS-Agarose ) A 087-06 0.6 ml none 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AEA-cAMPS-Agarose ) A 087-25 2.5 ml none 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AEA-cAMPS-Agarose ) A 087-60 6 ml none 2- (6- [ Biotinyl]aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-Biotin-AHA-cAMP ) B 041-01 1 μmol ~0.8 mg pending 2- (6- [ Biotinyl]aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-Biotin-AHA-cAMP ) B 041-05 5 x 1 μmol pending 2'- (6- [ Fluorescein]aminohexylcarbamoylguanosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cGMP ) F 004-01 1 μmol ~0.9 mg pending 2'- (6- [ Fluorescein]aminohexylcarbamoylguanosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cGMP ) F 004-05 5 x 1 μmol pending 2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cAMP ) F 003-01 1 μmol ~0.9 mg pending 2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cAMP ) F 003-05 5 x 1 μmol pending 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AHA-cAMP ) A 053-05 5 μmol ~2.2 mg 214276-80-9 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AHA-cAMP ) A 053-25 5 x 5 μmol 214276-80-9 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AHA-cAMP-Agarose ) A 054-06 0.6 ml none 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AHA-cAMP-Agarose ) A 054-25 2.5 ml none 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AHA-cAMP-Agarose ) A 054-60 6 ml none 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AHA-cAMPS ) A 068-05 5 μmol ~2.3 mg 214276-94-5 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AHA-cAMPS ) A 068-25 5 x 5 μmol 214276-94-5 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized to agarose gel ( Sp-2-AHA-cAMPS-Agarose ) A 069-06 0.6 ml none 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized to agarose gel ( Sp-2-AHA-cAMPS-Agarose ) A 069-25 2.5 ml none 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized to agarose gel ( Sp-2-AHA-cAMPS-Agarose ) A 069-60 6.0 ml none 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cAMP ) A 046-05 5 μmol ~2.4 mg pending 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cAMP ) A 046-25 5 x 5 μmol pending 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cAMP-Agarose ) A 058-06 0.6 ml none 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cAMP-Agarose ) A 058-25 2.5 ml none 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cAMP-Agarose ) A 058-60 6 ml none 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cAMPS ) A 066-05 5 μmol ~2.4 mg pending 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cAMPS ) A 066-25 5 x 5 μmol pending 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) A 050-06 0.6 ml none 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) A 050-25 2.5 ml none 2'- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) A 050-60 6 ml none 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cGMP ) A 048-05 5 μmol ~2.4 mg pending 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cGMP ) A 048-25 5 x 5 μmol pending 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cGMP-Agarose ) A 059-06 0.6 ml none 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cGMP-Agarose ) A 059-25 2.5 ml none 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2'-AHC-cGMP-Agarose ) A 059-60 6 ml none 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-2'-AHC-cGMPS-Agarose ) A 051-06 0.6 ml none 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-2'-AHC-cGMPS-Agarose ) A 051-25 2.5 ml none 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-2'-AHC-cGMPS-Agarose ) A 051-60 6 ml none 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cGMPS ) A 067-05 5 μmol ~2.5 mg pending 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cGMPS ) A 067-25 5 x 5 μmol pending 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cGMPS-Agarose ) A 052-06 0.6 ml none 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cGMPS-Agarose ) A 052-25 2.5 ml none 2'- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cGMPS-Agarose ) A 052-60 6 ml none 2- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-ADOA-cAMP ) A 136-05 5 μmol ~2.4 mg pending 2- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-ADOA-cAMP ) A 136-25 5 x 5 μmol pending 2'- / 3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- triphosphate ( 2'-/3'-AEC-ATP / EDA-ATP ) A 072-05 5 μmol ~3 mg 173074-70-9 2'- / 3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- triphosphate ( 2'-/3'-AEC-ATP / EDA-ATP ) A 072-25 5 x 5 μmol 173074-70-9 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- [(β, γ)- imido]triphosphate ( MANT-GppNHp ) M 047-01 1 μmol ~0.7 mg 148821-01-6 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- [(β, γ)- imido]triphosphate ( MANT-GppNHp ) M 047-05 5 x 1 μmol 148821-01-6 2'- /3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- diphosphate ( 2'-/3'-AEC-ADP / EDA-ADP ) A 118-05 5 μmol ~2.6 mg pending 2'- /3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- diphosphate ( 2'-/3'-AEC-ADP / EDA-ADP ) A 118-25 5 x 5 μmol pending 2'- Amino- 2'- deoxyadenosine ( 2'-AdA ) A 104-10 10 μmol ~2.7 mg 10414-81-0 2'- Amino- 2'- deoxyadenosine ( 2'-AdA ) A 104-50 5 x 10 μmol 10414-81-0 2'- Amino- 2'- deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-NH2-cAMP ) A 088-05 5 μmol ~1.8 mg 85819-83-6 2'- Amino- 2'- deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-NH2-cAMP ) A 088-25 5 x 5 μmol 85819-83-6 2'- Amino- 2'- deoxyadenosine- 5'- O- diphosphate ( 2'-NH2-ADP ) A 106-05 5 μmol ~2.1 mg 63545-57-3 2'- Amino- 2'- deoxyadenosine- 5'- O- diphosphate ( 2'-NH2-ADP ) A 106-25 5 x 5 μmol 63545-57-3 2'- Amino- 2'- deoxyadenosine- 5'- O- triphosphate ( 2'-NH2-ATP ) A 113-05 5 μmol ~2.5 mg 61468-88-0 2'- Amino- 2'- deoxyadenosine- 5'- O- triphosphate ( 2'-NH2-ATP ) A 113-25 5 x 5 μmol 61468-88-0 2- Amino- 6- chloropurine riboside- 5'- O- monophosphate ( 2-NH2-6-Cl-5'-PuMP ) A 084-05 5 μmol ~1.9 mg pending 2- Amino- 6- chloropurine riboside- 5'- O- monophosphate ( 2-NH2-6-Cl-5'-PuMP ) A 084-25 5 x 5 μmol pending 2- Aminopurine riboside- 3', 5'- monophosphate ( 2-NH2-cPuMP ) A 027-05 5 μmol ~1.8 mg 42467-66-3 2- Aminopurine riboside- 3', 5'- monophosphate ( 2-NH2-cPuMP ) A 027-25 5 x 5 μmol 42467-66-3 2- Aminopurine riboside- 5'- O- triphosphate ( 2-NH2-PuTP ) A 124-05 5 μmol ~2.5 mg 23001-60-7 2- Aminopurine riboside- 5'- O- triphosphate ( 2-NH2-PuTP ) A 124-25 5 x 5 μmol 23001-60-7 2- Aza- 1, N6- ethenoadenosine ( 2-Aza-ε-Ado ) A 086-10 10 μmol ~2.9 mg 50663-82-6 2- Aza- 1, N6- ethenoadenosine ( 2-Aza-ε-Ado ) A 086-50 5 x 10 μmol 50663-82-6 2- Aza- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 2-Aza-ε-cAMP ) A 015-05 5 μmol ~1.9 mg 50663-90-6 2- Aza- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 2-Aza-ε-cAMP ) A 015-25 5 x 5 μmol 50663-90-6 2- Chloro- 2'- deoxyadenosine ( 2-Cl-dAdo, Cladribine ) C 028-100 100 μmol ~29 mg 4291-63-8 2- Chloro- 2'- deoxyadenosine ( 2-Cl-dAdo, Cladribine ) C 028-500 5 x 100 μmol 4291-63-8 2- Chloro- 8- methylaminoadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-8-MA-cAMP ) C 080-05 5 μmol ~2.1 mg 96990-16-8 2- Chloro- 8- methylaminoadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-8-MA-cAMP ) C 080-25 5 x 5 μmol 96990-16-8 2- Chloroadenine ( 2-Cl-Ade ) C 040-10 10 μmol ~1.7 mg 1839-18-5 2- Chloroadenine ( 2-Cl-Ade ) C 040-50 5 x 10 μmol 1839-18-5 2- Chloroadenosine ( 2-Cl-Ado ) C 017-100 100 μmol ~30 mg 146-77-0 2- Chloroadenosine ( 2-Cl-Ado ) C 017-500 5 x 100 μmol 146-77-0 2- Chloroadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-cAMP ) C 020-05 5 μmol ~1.9 mg 39023-65-9 2- Chloroadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-cAMP ) C 020-25 5 x 5 μmol 39023-65-9 2- Chloroadenosine- 5'- O- diphosphate ( 2-Cl-5'-ADP ) C 055-05 5 μmol ~2.3 mg 16506-88-0 2- Chloroadenosine- 5'- O- diphosphate ( 2-Cl-5'-ADP ) C 055-25 5 x 5 μmol 16506-88-0 2- Chloroadenosine- 5'- O- monophosphate ( 2-Cl-5'-AMP ) C 054-10 10 μmol ~3.8 mg 21466-01-3 2- Chloroadenosine- 5'- O- monophosphate ( 2-Cl-5'-AMP ) C 054-50 5 x 10 μmol 21466-01-3 2- Chloroadenosine- 5'- O- triphosphate ( 2-Cl-ATP ) C 039-05 5 μmol ~2.7 mg 49564-60-5 2- Chloroadenosine- 5'- O- triphosphate ( 2-Cl-ATP ) C 039-25 5 x 5 μmol 49564-60-5 2- Chloroinosine ( 2-Cl-Ino ) C 021-10 10 μmol ~3 mg 13276-43-2 2- Chloroinosine ( 2-Cl-Ino ) C 021-50 5 x 10 μmol 13276-43-2 2- Chloroinosine- 3', 5'- cyclic monophosphate ( 2-Cl-cIMP ) C 029-05 5 μmol ~1.9 mg 52301-30-1 2- Chloroinosine- 3', 5'- cyclic monophosphate ( 2-Cl-cIMP ) C 029-25 5 x 5 μmol 52301-30-1 2'- Deoxy- 1, N6- ethenoadenosine ( ε-dAdo ) D 080-05 5 μmol ~1.4 mg 68498-25-9 2'- Deoxy- 1, N6- ethenoadenosine ( ε-dAdo ) D 080-25 5 x 5 μmol 68498-25-9 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- monophosphate ( ε-5'-dAMP ) D 077-05 5 μmol ~1.8 mg 60508-81-8 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- triphosphate ( ε-dATP ) D 078-05 5 μmol ~2.6 mg 81004-54-8 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- triphosphate ( ε-dATP ) D 078-25 5 x 5 μmol 81004-54-8 2'- Deoxy- 2'- fluoroadenosine ( 2'-F-dAdo ) D 079-05 5 μmol ~1.3 mg 64183-27-3 2'- Deoxy- 2'- fluoroadenosine ( 2'-F-dAdo ) D 079-25 5 x 5 μmol 64183-27-3 2'- Deoxy- 2'- fluoroadenosine- 3', 5'- cyclic monophosphate ( 2'-F-cAMP ) D 073-05 5 μmol ~1.8 mg 81356-81-2 2'- Deoxy- 2'- fluoroadenosine- 3', 5'- cyclic monophosphate ( 2'-F-cAMP ) D 073-25 5 x 5 μmol 81356-81-2 2'- Deoxy- 2'- fluoroadenosine- 5'- O- triphosphate ( 2'-F-ATP ) D 074-05 5 μmol ~2.5 mg 73449-07-7 2'- Deoxy- 2'- fluoroadenosine- 5'- O- triphosphate ( 2'-F-ATP ) D 074-25 5 x 5 μmol 73449-07-7 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-dADP ) D 083-05 5 μmol ~2.7 mg 91828-83-0 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-dADP ) D 083-25 5 x 5 μmol 91828-83-0 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-dAMP) D 081-05 5 μmol ~2.3 mg pending 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-dAMP) D 081-25 5 x 5 μmol pending 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-dATP ) D 085-05 5 μmol ~3.1 mg 128113-53-1 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-dATP ) D 085-25 5 x 5 μmol 128113-53-1 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-dGDP ) D 084-05 5 μmol ~2.8 mg 127383-33-9 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-dGDP ) D 084-25 5 x 5 μmol 127383-33-9 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-dGMP ) D 082-05 5 μmol ~2.4 mg pending 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-dGMP ) D 082-25 5 x 5 μmol pending 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-dGTP ) D 086-05 5 μmol ~3.2 mg 124615-99-2 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-dGTP ) D 086-25 5 x 5 μmol 124615-99-2 2'- Deoxy- 8- hydroxyadenosine ( 8-OH-dAdo ) D 050-05 5 μmol ~1.3 mg 62471-63-0 2'- Deoxy- 8- hydroxyadenosine ( 8-OH-dAdo ) D 050-25 5 x 5 μmol 62471-63-0 2'- Deoxy- 8- hydroxyguanosine ( 8-OH-dGuo ) D 022-05 5 μmol ~1.5 mg 88847-89-6 2'- Deoxy- 8- hydroxyguanosine ( 8-OH-dGuo ) D 022-25 5 x 5 μmol 88847-89-6 2'- Deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-dcAMP ) D 015-10 10 μmol ~3.4 mg 93839-95-3 2'- Deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-dcAMP ) D 015-50 5 x 10 μmol 93839-95-3 2'- Deoxyadenosine- 3', 5'- O- bisphosphate ( pdAp ) D 092-05 5 μmol ~2.1 mg 16174-58-6 2'- Deoxyadenosine- 3', 5'- O- bisphosphate ( pdAp ) D 092-25 5 x 5 μmol 16174-58-6 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-dADP-α-S ) D 004-05 5 μmol ~2.1 mg 120496-69-7 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-dADP-α-S ) D 004-25 5 x 5 μmol 120496-69-7 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-dADP-α-S ) D 005-05 5 μmol ~2.1 mg 120496-69-7 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-dADP-α-S ) D 005-25 5 x 5 μmol 120496-69-7 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dATP-α-S ) D 006-05 5 μmol ~2.5 mg 87358-15-4 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dATP-α-S ) D 006-25 5 x 5 μmol 87358-15-4 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dATP-α-S ) D 007-05 5 μmol ~2.5 mg 80875-87-2 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dATP-α-S ) D 007-25 5 x 5 μmol 80875-87-2 2'- Deoxyadenosine- 5'- O- monophosphorothioate ( 5'-dAMPS ) D 003-05 5 μmol ~1.7 mg 64145-26-2 2'- Deoxyadenosine- 5'- O- monophosphorothioate ( 5'-dAMPS ) D 003-25 5 x 5 μmol 64145-26-2 2'- Deoxycytidine- 3', 5'- O- bisphosphate ( pdCp ) D 093-05 5 μmol 1.9 mg 4682-43-3 2'- Deoxycytidine- 3', 5'- O- bisphosphate ( pdCp ) D 093-25 5 x 5 μmol 4682-43-3 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dCTP-α-S ) D 046-05 5 μmol ~2.4 mg 80951-76-4 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dCTP-α-S ) D 046-25 5 x 5 μmol 80951-76-4 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dCTP-α-S ) D 047-05 5 μmol ~2.4 mg 80951-75-3 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dCTP-α-S ) D 047-25 5 x 5 μmol 80951-75-3 2'- Deoxycytidine- 5'- O- monophosphorothioate ( 5'-dCMPS ) D 059-05 5 μmol ~1.6 mg 64145-27-3 2'- Deoxycytidine- 5'- O- monophosphorothioate ( 5'-dCMPS ) D 059-25 5 x 5 μmol 64145-27-3 2'- Deoxyguanosine- 3', 5'- cyclic monophosphate ( 2'-dcGMP ) D 020-10 10 μmol ~3.5 mg 93919-42-7 2'- Deoxyguanosine- 3', 5'- cyclic monophosphate ( 2'-dcGMP ) D 020-50 5 x 10 μmol 93919-42-7 2'- Deoxyguanosine- 3', 5'- O- bisphosphate ( pdGp ) D 094-05 5 μmol ~2.1 mg 16174-59-7 2'- Deoxyguanosine- 3', 5'- O- bisphosphate ( pdGp ) D 094-25 5 x 5 μmol 16174-59-7 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dGTP-α-S ) D 030-05 5 μmol ~2.6 mg 80902-29-0 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dGTP-α-S ) D 030-25 5 x 5 μmol 80902-29-0 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dGTP-α-S ) D 031-05 5 μmol ~2.6 mg 80902-28-9 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dGTP-α-S ) D 031-25 5 x 5 μmol 80902-28-9 2'- Deoxyguanosine- 5'- O- monophosphorothioate ( 5'-dGMPS ) D 056-05 5 μmol ~1.8 mg 87358-26-7 2'- Deoxyguanosine- 5'- O- monophosphorothioate ( 5'-dGMPS ) D 056-25 5 x 5 μmol 87358-26-7 2'- Deoxyinosine- 5'- O- monophosphorothioate ( 5'-dIMPS ) D 060-05 5 μmol ~1.7 mg 771477-45-3 2'- Deoxyinosine- 5'- O- monophosphorothioate ( 5'-dIMPS ) D 060-25 5 x 5 μmol 771477-45-3 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dUTP-α-S ) D 048-05 5 μmol ~2.4 mg 170428-85-0 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dUTP-α-S ) D 048-25 5 x 5 μmol 170428-85-0 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dUTP-α-S ) D 049-05 5 μmol ~2.4 mg 170428-85-0 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dUTP-α-S ) D 049-25 5 x 5 μmol 170428-85-0 2'- Deoxyuridine- 5'- O- monophosphosphorothioate ( 5'-dUMPS ) D 057-05 5 μmol ~1.6 mg 205379-91-5 2'- Deoxyuridine- 5'- O- monophosphosphorothioate ( 5'-dUMPS ) D 057-25 5 x 5 μmol 205379-91-5 2- Methylthioadenosine ( 2-MeS-Ado ) M 033-10 10 μmol ~3.1 mg 4105-39-9 2- Methylthioadenosine ( 2-MeS-Ado ) M 033-50 5 x 10 μmol 4105-39-9 2- Methylthioadenosine- 5'- O- diphosphate ( 2-MeS-ADP ) M 020-05 5 μmol ~2.4 mg 34983-48-7 2- Methylthioadenosine- 5'- O- diphosphate ( 2-MeS-ADP ) M 020-25 5 x 5 μmol 34983-48-7 2- Methylthioadenosine- 5'- O- monophosphate ( 2-MeS-5'-AMP ) M 031-10 10 μmol ~3.9 mg 22140-20-1 2- Methylthioadenosine- 5'- O- monophosphate ( 2-MeS-5'-AMP ) M 031-50 5 x 10 μmol 22140-20-1 2- Methylthioadenosine- 5'- O- triphosphate ( 2-MeS-ATP ) M 021-05 5 μmol ~2.8 mg 43170-89-4 2- Methylthioadenosine- 5'- O- triphosphate ( 2-MeS-ATP ) M 021-25 5 x 5 μmol 43170-89-4 2'- O- ( N- Methylanthraniloyl)adenosine- 3', 5'- cyclic monophosphate ( MANT-cAMP ) M 008-10 10 μmol ~4.8 mg 83707-14-6 2'- O- ( N- Methylanthraniloyl)adenosine- 3', 5'- cyclic monophosphate ( MANT-cAMP ) M 008-50 5 x 10 μmol 83707-14-6 2'- O- ( N- Methylanthraniloyl)guanosine- 3', 5'- cyclic monophosphate ( MANT-cGMP ) M 009-10 10 μmol ~5 mg 83707-15-7 2'- O- ( N- Methylanthraniloyl)guanosine- 3', 5'- cyclic monophosphate ( MANT-cGMP ) M 009-50 5 x 10 μmol 83707-15-7 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cAMP / 2'-EDA-cAMP ) A 098-05 5 μmol ~2.1 mg 403497-54-1 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cAMP / 2'-EDA-cAMP ) A 098-25 5 x 5 μmol 403497-54-1 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AEC-cAMPS / Rp-2'-EDA-cAMPS ) A 119-05 5 μmol ~2.2 mg pending 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AEC-cAMPS / Rp-2'-EDA-cAMPS ) A 119-25 5 x 5 μmol pending 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AEC-cAMPS / Sp-2'-EDA-cAMPS ) A 095-05 5 μmol ~2.2 mg pending 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AEC-cAMPS / Sp-2'-EDA-cAMPS ) A 095-25 5 x 5 μmol pending 2'- O- (2- Aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cGMP ) A 075-05 5 μmol ~2.2 mg pending 2'- O- (2- Aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cGMP ) A 075-25 5 x 5 μmol pending 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cAMP-Agarose ) A 112-06 0.6 ml none 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cAMP-Agarose ) A 112-25 2.5 ml none 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cAMP-Agarose ) A 112-60 6 ml none 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) A 122-06 0.6 ml none 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) A 122-25 2.5 ml none 2'- O- (6- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) A 122-60 6 ml none 2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cAMPS ) A 120-25 5 x 5 μmol pending 2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cGMPS ) A 123-05 5 μmol ~2.5 mg none 2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cGMPS ) A 123-25 5 x 5 μmol none 2'- O- (6-?Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cAMPS ) A 120-05 5 μmol ~2.4 mg pending 2'- O- (N'- Methylanthraniloyl)cytidine- 3', 5'- cyclic monophosphate ( MANT-cCMP ) M 053-05 5 μmol ~2.3 mg pending 2'- O- (N'- Methylanthraniloyl)cytidine- 3', 5'- cyclic monophosphate ( MANT-cCMP ) M 053-25 5 x 5 μmol pending 2'- O- Methyladenosine ( 2'-O-Me-Ado ) M 054-10 10 μmol ~2.8 mg 2140-79-6 2'- O- Methyladenosine ( 2'-O-Me-Ado ) M 054-50 5 x 10 μmol 2140-79-6 2'- O- Methyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cAMP ) M 050-05 5 μmol ~1.8 mg 40269-29-2 2'- O- Methyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cAMP ) M 050-25 5 x 5 μmol 40269-29-2 2'- O- Methylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cGMP ) M 036-05 5 μmol ~1.9 mg pending 2'- O- Methylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cGMP ) M 036-25 5 x 5 μmol pending 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 2-MB-cAMP ) M 007-250 5 x 50 μmol 55443-13-5 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 2-MB-cAMP ) M 007-50 50 μmol ~21 mg 55443-13-5 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-O-MB-cAMPS ) M 004-05 5 μmol ~2.2 mg 152218-23-0 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-O-MB-cAMPS ) M 004-25 5 x 5 μmol 152218-23-0 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-O-MB-cAMPS ) M 005-05 5 μmol ~2.2 mg 152218-23-0 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-O-MB-cAMPS ) M 005-25 5 x 5 μmol 152218-23-0 2'- O- Monobutyrylguanosine- 3', 5'- cyclic monophosphate ( MB-cGMP ) M 006-10 10 μmol ~4.4 mg 58329-72-9 2'- O- Monobutyrylguanosine- 3', 5'- cyclic monophosphate ( MB-cGMP ) M 006-50 5 x 10 μmol 58329-72-9 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cAMP ) M 011-125 5 x 25 μmol 36940-87-1 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cAMP ) M 011-25 25 μmol ~11 mg 36940-87-1 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cAMP ) M 022-01 1 μmol ~0.6 mg 104809-08-7 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cAMP ) M 022-05 5 x 1 μmol 104809-08-7 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cGMP ) M 015-125 5 x 25 μmol 39118-26-8 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cGMP ) M 015-25 25 μmol ~12 mg 39118-26-8 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cGMP ) M 023-01 1 μmol ~0.6 mg 104872-93-7 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cGMP ) M 023-05 5 x 1 μmol 104872-93-7 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) D 101-001 0.1 μmol ~0.1 mg pending 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) D 101-005 5 x 0.1 μmol pending 2', 3'- Dideoxyadenosine ( ddA ) D 002-125 5 x 25 μmol 4097-22-7 2', 3'- Dideoxyadenosine ( ddA ) D 002-25 25 μmol ~5.9 mg 4097-22-7 2', 3'- Dideoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- /Sp- isomers ( Rp-/Sp-ddATP-α-S ) D 026-05 5 μmol ~2.5 mg 154902-26-8 2', 3'- Dideoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- /Sp- isomers ( Rp-/Sp-ddATP-α-S ) D 026-25 5 x 5 μmol 154902-26-8 2', 3'- Dideoxyadenosine- 5'- O- triphosphate ( ddATP ) D 018-05 5 μmol ~2.4 mg 132619-65-9 2', 3'- Dideoxyadenosine- 5'- O- triphosphate ( ddATP ) D 018-25 5 x 5 μmol 132619-65-9 2', 3'- Dideoxycytidine- 5'- O- (1- thiotriphosphate), Rp-/Sp- isomers ( Rp-/Sp-ddCTP-α-S ) D 027-05 5 μmol ~2.4 mg 154771-49-0 2', 3'- Dideoxycytidine- 5'- O- (1- thiotriphosphate), Rp-/Sp- isomers ( Rp-/Sp-ddCTP-α-S ) D 027-25 5 x 5 μmol 154771-49-0 2', 3'- Dideoxycytidine- 5'- O- triphosphate ( ddCTP ) D 037-05 5 μmol ~2.3 mg 132619-66-0 2', 3'- Dideoxycytidine- 5'- O- triphosphate ( ddCTP ) D 037-25 5 x 5 μmol 132619-66-0 2', 3'- Dideoxyguanosine ( ddG ) D 039-250 5 x 50 μmol 085326-06-3 2', 3'- Dideoxyguanosine ( ddG ) D 039-50 50 μmol ~13 mg 085326-06-3 2', 3'- Dideoxyguanosine- 5'- O- (1- thiotriphosphate), Rp-/Sp- isomers ( Rp-/Sp-ddGTP-α-S ) D 025-05 5 μmol ~2.5 mg 154771-50-3 2', 3'- Dideoxyguanosine- 5'- O- (1- thiotriphosphate), Rp-/Sp- isomers ( Rp-/Sp-ddGTP-α-S ) D 025-25 5 x 5 μmol 154771-50-3 2', 3'- Dideoxyguanosine- 5'- O- triphosphate ( ddGTP ) D 019-05 5 μmol ~2.5 mg 68726-28-3 2', 3'- Dideoxyguanosine- 5'- O- triphosphate ( ddGTP ) D 019-25 5 x 5 μmol 68726-28-3 2', 3'- Dideoxythymidine- 5'- O- (1- thiotriphosphate), Rp-/Sp-isomers ( Rp-/Sp-ddTTP-α-S ) D 029-05 5 μmol ~2.4 mg 154771-48-9 2', 3'- Dideoxythymidine- 5'- O- (1- thiotriphosphate), Rp-/Sp-isomers ( Rp-/Sp-ddTTP-α-S ) D 029-25 5 x 5 μmol 154771-48-9 2', 3'- Dideoxyuridine- 5'- O- (1- thiotriphosphate), Rp- / Sp- isomers ( Rp-/Sp-ddUTP-α-S ) D 028-05 5 μmol ~2.3 mg pending 2', 3'- Dideoxyuridine- 5'- O- (1- thiotriphosphate), Rp- / Sp- isomers ( Rp-/Sp-ddUTP-α-S ) D 028-25 5 x 5 μmol pending 2'-, 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-GMP ) M 042-10 10 μmol ~5 mg 85287-54-3 2'-, 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-GMP ) M 042-50 5 x 10 μmol 85287-54-3 2'-/3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-ADP ) M 040-05 5 μmol ~2.8 mg 151481-85-5 2'-/3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-ADP ) M 040-25 5 x 5 μmol 151481-85-5 2'-/3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-AMP ) M 037-10 10 μmol ~4.8 mg 85287-54-3 2'-/3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-AMP ) M 037-50 5 x 10 μmol 85287-54-3 2'-/3'- O- (N- Methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-ATP ) M 030-05 5 μmol ~3.2 mg 151481-86-6 2'-/3'- O- (N- Methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-ATP ) M 030-25 5 x 5 μmol 151481-86-6 2'-/3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-GDP ) M 041-05 5 μmol ~2.9 mg 148821-02-7 2'-/3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-GDP ) M 041-25 5 x 5 μmol 148821-02-7 2'-/3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-GTP ) M 032-05 5 μmol ~3.3 mg 148821-03-8 2'-/3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-GTP ) M 032-25 5 x 5 μmol 148821-03-8 3'- Amino- 3'- deoxyadenosine ( 3'-AdA ) A 063-10 10 μmol ~2.7 mg 2504-55-4 3'- Amino- 3'- deoxyadenosine ( 3'-AdA ) A 063-50 5 x 10 μmol 2504-55-4 3'- Amino- 3'- deoxyadenosine- 5'- O- diphosphate ( 3'-NH2-ADP ) A 107-05 5 μmol ~2.1 mg [4360-06-9] 3'- Amino- 3'- deoxyadenosine- 5'- O- diphosphate ( 3'-NH2-ADP ) A 107-25 5 x 5 μmol [4360-06-9] 3'- Amino- 3'- deoxyadenosine- 5'- O- triphosphate ( 3'-NH2-ATP ) A 114-05 5 μmol ~2.5 mg 4209-30-7 3'- Amino- 3'- deoxyadenosine- 5'- O- triphosphate ( 3'-NH2-ATP ) A 114-25 5 x 5 μmol 4209-30-7 3'- Amino- 3'- deoxyguanosine ( 3'-AdG ) A 064-10 10 μmol ~2.8 mg 80015-76-5 3'- Amino- 3'- deoxyguanosine ( 3'-AdG ) A 064-50 5 x 10 μmol 80015-76-5 3'- Deoxyguanosine ( 3'-dG ) D 041-250 5 x 50 μmol 3608-58-0 3'- Deoxyguanosine ( 3'-dG ) D 041-50 50 μmol ~13 mg 3608-58-0 3'- Deoxythymidine / 2', 3'- Dideoxythymidine ( ddT ) D 040-100 100 μmol ~23 mg [3416-05-5] 3'- Deoxythymidine / 2', 3'- Dideoxythymidine ( ddT ) D 040-500 5 x 100 μmol [3416-05-5] 3'- Deoxythymidine- 5'- O- triphosphate ( dTTP ) / 2', 3'- Dideoxythymidine- 5'- triphosphate ( ddTTP ) D 038-05 5 μmol ~2.3 mg 128524-26-5 3'- Deoxythymidine- 5'- O- triphosphate ( dTTP ) / 2', 3'- Dideoxythymidine- 5'- triphosphate ( ddTTP ) D 038-25 5 x 5 μmol 128524-26-5 3', 5'- Diamino- 3', 5'- dideoxyadenosine ( 3',5'-DA-ddA ) D 076-05 5 μmol ~1.3 mg 67313-23-9 3', 5'- Diamino- 3', 5'- dideoxyadenosine ( 3',5'-DA-ddA ) D 076-25 5 x 5 μmol 67313-23-9 4- Nitrobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 4-NO2-cBIMP ) N 007-05 5 μmol ~1.9 mg 127634-21-3 4- Nitrobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 4-NO2-cBIMP ) N 007-25 5 x 5 μmol 127634-21-3 5- (3- Aminoallyl)- 2'- deoxyuridine- 5'- O- triphosphate ( AA-dUTP ) A 116-05 5 μmol ~2.6 mg 109921-28-0 5- (3- Aminoallyl)- 2'- deoxyuridine- 5'- O- triphosphate ( AA-dUTP ) A 116-25 5 x 5 μmol 109921-28-0 5- (3- Aminoallyl)uridine- 5'- O- triphosphate ( AA-UTP ) A 117-05 5 μmol ~2.7 mg 75221-88-4 5- (3- Aminoallyl)uridine- 5'- O- triphosphate ( AA-UTP ) A 117-25 5 x 5 μmol 75221-88-4 5'- [(2, 2, 5, 5- Tetramethyl- 3- pyrrolin- 1- oxyl- 3- carboxylamino)adenosine ( 5'-TMPO-Ado ) T 010-05 5 μmol ~2.2 mg pending 5'- [(2, 2, 5, 5- Tetramethyl- 3- pyrrolin- 1- oxyl- 3- carboxylamino)adenosine ( 5'-TMPO-Ado ) T 010-25 5 x 5 μmol pending 5'- Amino- 5'- deoxyadenosine ( 5'-NH2-Ado ) A 021-10 10 μmol ~2.7 mg 14365-44-7 5'- Amino- 5'- deoxyadenosine ( 5'-NH2-Ado ) A 021-50 5 x 10 μmol 14365-44-7 5- Aminoimidazole- 4- carboxamide- 1- ß- D- ribofuranoside ( AICAR / Acadesine / Z- riboside ) A 103-10 10 μmol ~2.6 mg 2627-69-2 5- Aminoimidazole- 4- carboxamide- 1- ß- D- ribofuranoside ( AICAR / Acadesine / Z- riboside ) A 103-50 5 x 10 μmol 2627-69-2 5- Aminoimidazole- 4- carboxamide- 1- ß- D- ribofuranoside- 5'- O- monophosphate ( AICAR-5'-MP / ZMP ) A 105-10 10 μmol ~3.4 mg 3031-94-5 5- Aminoimidazole- 4- carboxamide- 1- ß- D- ribofuranoside- 5'- O- monophosphate ( AICAR-5'-MP / ZMP ) A 105-50 5 x 10 μmol 3031-94-5 5- Chloro- 2'- deoxycytidine ( CldC ) C 081-05 5 μmol ~2.1 mg 32387-56-7 5- Chloro- 2'- deoxycytidine ( CldC ) C 081-25 5 x 5 μmol 32387-56-7 5- Chlorocytidine ( 5-C-C ) C 034-05 5 μmol ~1.4 mg 25130-29-4 5- Chlorocytidine ( 5-C-C ) C 034-25 5 x 5 μmol 25130-29-4 5- Chlorouridine ( 5-Cl-U ) C 035-05 5 μmol ~1.4 mg 2880-89-9 5- Chlorouridine ( 5-Cl-U ) C 035-25 5 x 5 μmol 2880-89-9 5- Iodotubercidin / 7- Deaza- 7- iodoadenosine ( 5-I-Tu ) I 004-05 5 μmol ~2 mg 4386-93- 5- Iodotubercidin / 7- Deaza- 7- iodoadenosine ( 5-I-Tu ) I 004-25 5 x 5 μmol 4386-93- 5'- Phosphoguanylyl- (3' → 5')- guanosine ( pGpG ) P 023-001 0.1 μmol ~71 μg 33008-99-0 5'- Phosphoguanylyl- (3' → 5')- guanosine ( pGpG ) P 023-005 5 x 0.1 μmol 33008-99-0 5, 6- Dichlorobenzimidazole riboside (DRB) D 012-100 100 μmol ~32 mg 53-85-0 5, 6- Dichlorobenzimidazole riboside (DRB) D 012-500 5 x 100 μmol 53-85-0 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Rp- isomer ( Rp-5,6-DCl-cBIMPS ) D 013-05 5 μmol ~2.1 mg 120912-55-2 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Rp- isomer ( Rp-5,6-DCl-cBIMPS ) D 013-25 5 x 5 μmol 120912-55-2 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Sp- isomer ( Sp-5,6-DCl-cBIMPS ) D 014-05 5 μmol ~2.1 mg 120912-54-1 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Sp- isomer ( Sp-5,6-DCl-cBIMPS ) D 014-25 5 x 5 μmol 120912-54-1 5, 6- Dichlorobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DCl-cBIMP ) D 011-10 10 μmol ~4 mg 129693-10-3 5, 6- Dichlorobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DCl-cBIMP ) D 011-50 5 x 10 μmol 129693-10-3 5, 6- Dimethylbenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DM-cBIMP ) D 001-05 5 μmol ~1.8 mg 142754-31-2 5, 6- Dimethylbenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DM-cBIMP ) D 001-25 5 x 5 μmol 142754-31-2 6- Bromotubercidin ( 8- Bromo- 7- deazaadenosine, 6-Br-Tu ) B 013-05 5 μmol ~1.7 mg 78000-56-3 6- Bromotubercidin ( 8- Bromo- 7- deazaadenosine, 6-Br-Tu ) B 013-25 5 x 5 μmol 78000-56-3 6- Chloropurine riboside- 3', 5'- cyclic monophosphate ( 6-Cl-cPuMP ) C 002-05 5 μmol ~1.9 mg 94200-58-5 6- Chloropurine riboside- 3', 5'- cyclic monophosphate ( 6-Cl-cPuMP ) C 002-25 5 x 5 μmol 94200-58-5 6- Chloropurine riboside- 5'- O- diphosphate ( 6-Cl-PuDP ) C 015-05 5 μmol ~2.2 mg 59128-86-8 6- Chloropurine riboside- 5'- O- diphosphate ( 6-Cl-PuDP ) C 015-25 5 x 5 μmol 59128-86-8 6- Chloropurine riboside- 5'- O- monophosphate ( 6-Cl-5'-PuMP ) C 032-10 10 μmol ~3.7 mg 5843-59-4 6- Chloropurine riboside- 5'- O- monophosphate ( 6-Cl-5'-PuMP ) C 032-50 5 x 10 μmol 5843-59-4 6- Chloropurine riboside- 5'- O- triphosphate ( 6-Cl-PuTP ) C 049-05 5 μmol ~2.6 mg 55673-61-5 6- Chloropurine riboside- 5'- O- triphosphate ( 6-Cl-PuTP ) C 049-25 5 x 5 μmol 55673-61-5 6, 7- Bis(carboxymethoxy)coumarin- 4- yl)methyl- adenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cAMP ) B 016-001 0.1 μmol ~68 μg 339291-51-9 6, 7- Bis(carboxymethoxy)coumarin- 4- yl)methyl- adenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cAMP ) B 016-005 5 x 0.1 μmol 339291-51-9 7- Deaza- 2'- deoxyadenosine- 5'- O- diphosphate ( 7-CH-dADP ) D 061-05 5 μmol ~2.1 mg 187478-96-2 7- Deaza- 2'- deoxyadenosine- 5'- O- diphosphate ( 7-CH-dADP ) D 061-25 5 x 5 μmol 187478-96-2 7- Deaza- 2'- deoxyadenosine- 5'- O- monophosphate ( 7-CH-5'-dAMP/dTuMP ) D 058-05 5 μmol ~1.7 mg 103078-56-4 7- Deaza- 2'- deoxyadenosine- 5'- O- monophosphate ( 7-CH-5'-dAMP/dTuMP ) D 058-25 5 x 5 μmol 103078-56-4 7- Deaza- 2'- deoxyadenosine- 5'- O- triphosphate ( 7-CH-dATP ) D 033-05 5 μmol ~2.5 mg 67460-15-5 7- Deaza- 2'- deoxyadenosine- 5'- O- triphosphate ( 7-CH-dATP ) D 033-25 5 x 5 μmol 67460-15-5 7- Deazaadenosine- 3', 5'- cyclic monophosphate ( 7-CH-cAMP ) D 021-05 5 μmol ~1.8 mg 16719-36-1 7- Deazaadenosine- 3', 5'- cyclic monophosphate ( 7-CH-cAMP ) D 021-25 5 x 5 μmol 16719-36-1 7- Deazaadenosine- 5'- O- diphosphate ( 7-CH-ADP ) D 091-05 5 μmol ~2.1 mg 21080-53-5 7- Deazaadenosine- 5'- O- diphosphate ( 7-CH-ADP ) D 091-25 5 x 5 μmol 21080-53-5 7- Deazaadenosine- 5'- O- monophosphate ( 7-CH-5'-AMP/TuMP ) D 032-10 10 μmol ~3.5 mg 16719-46-3 7- Deazaadenosine- 5'- O- monophosphate ( 7-CH-5'-AMP/TuMP ) D 032-50 5 x 10 μmol 16719-46-3 7- Deazaadenosine- 5'- O- triphosphate ( 7-CH-ATP ) D 096-05 5 μmol ~2.5 mg 10058-66-9 7- Deazaadenosine- 5'- O- triphosphate ( 7-CH-ATP ) D 096-25 5 x 5 μmol 10058-66-9 7- Deazaguanosine- 3', 5'- cyclic monophosphate ( 7-CH-cGMP ) D 099-05 5 μmol ~1.8 mg 81611-03-2 7- Deazaguanosine- 3', 5'- cyclic monophosphate ( 7-CH-cGMP ) D 099-25 5 x 5 μmol 81611-03-2 8- (2- [ Biotinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cAMP ) B 030-01 1 μmol ~0.8 mg pending 8- (2- [ Biotinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cAMP ) B 030-05 5 x 1 μmol pending 8- (2- [ Biotinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cGMP ) B 025-01 1 μmol ~0.8 mg pending 8- (2- [ Biotinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cGMP ) B 025-05 5 x 1 μmol pending 8- (2- [ DY-547]- aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-2'-O-Me-cAMP ) D 089-001 0.1 μmol ~0.1 mg pending 8- (2- [ DY-547]- aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-2'-O-Me-cAMP ) D 089-005 5 x 0.1 μmol pending 8- (2- [ DY-547]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cGMP ) D 087-001 0.1 μmol ~0.1 mg pending 8- (2- [ DY-547]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cGMP ) D 087-005 5 x 0.1 μmol pending 8- (2- [ DY-647]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-647]-AET-cGMP ) D 090-001 0.1 μmol ~0.1 mg pending 8- (2- [ DY-647]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-647]-AET-cGMP ) D 090-005 5 x 0.1 μmol pending 8- (2- [ Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-Fluo-cAMP ) F 002-01 1 μmol ~0.8 mg 293296-57-8 8- (2- [ Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-Fluo-cAMP ) F 002-05 5 x 1 μmol 293296-57-8 8- (2- [ Fluoresceinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-Fluo-cGMP ) F 001-01 1 μmol ~0.8 mg pending 8- (2- [ Fluoresceinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-Fluo-cGMP ) F 001-05 5 x 1 μmol pending 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-NBD-cAMP ) N 002-01 1 μmol ~0.6 mg 221905-51-7 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-NBD-cAMP ) N 002-05 5 x 1 μmol 221905-51-7 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-NBD-cGMP ) N 001-01 1 μmol ~0.7 mg 115993-88-9 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-NBD-cGMP ) N 001-05 5 x 1 μmol 115993-88-9 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AEA-cAMP ) A 016-05 5 μmol ~1.9 mg 61363-29-9 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AEA-cAMP ) A 016-25 5 x 5 μmol 61363-29-9 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AEA-cAMP-Agarose ) A 020-06 0.6 ml none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AEA-cAMP-Agarose ) A 020-25 2.5 ml none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AEA-cAMP-Agarose ) A 020-60 6 ml none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AEA-cAMPS-Agarose ) A 007-06 0.6 ml none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AEA-cAMPS-Agarose ) A 007-25 2.5 ml none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AEA-cAMPS-Agarose ) A 007-60 6 ml none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AEA-cAMPS ) A 094-05 5 μmol ~2 mg 221904-84-3 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AEA-cAMPS ) A 094-25 5 x 5 μmol 221904-84-3 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AEA-cAMPS-Agarose ) A 008-06 0.6 ml none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AEA-cAMPS-Agarose ) A 008-25 2.5 ml none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AEA-cAMPS-Agarose ) A 008-60 6 ml none 8- (2- Aminoethylthio)- cyclic inosine diphosphate ribose ( 8-AET-N1-cIDPR ), sodium salt A 140-005 0.5 μmol ~309 μg pending 8- (2- Aminoethylthio)- cyclic inosine diphosphate ribose ( 8-AET-N1-cIDPR ), sodium salt A 140-025 5 x 0.5 μmol pending 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-AET-cGMP ) A 029-05 5 μmol ~2.1 mg 115974-70-4 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-AET-cGMP ) A 029-25 5 x 5 μmol 115974-70-4 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AET-cGMP-Agarose ) A 019-06 0.6 ml none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AET-cGMP-Agarose ) A 019-25 2.5 ml none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 8-AET-cGMP-Agarose ) A 019-60 6 ml none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AET-cGMPS-Agarose ) A 009-06 0.6 ml none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AET-cGMPS-Agarose ) A 009-25 2.5 ml none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AET-cGMPS-Agarose ) A 009-60 6 ml none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AET-cGMPS-Agarose ) A 010-06 0.6 ml none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AET-cGMPS-Agarose ) A 010-25 2.5 ml none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose ( Sp-8-AET-cGMPS-Agarose ) A 010-60 6 ml none 8- (2- Aminophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-APT-cGMP ) A 032-05 5 μmol ~2.4 mg 144509-87-5 8- (2- Aminophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-APT-cGMP ) A 032-25 5 x 5 μmol 144509-87-5 8- (4- [N- Methylanthraniloyl]aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-MABA-cAMP ) M 016-05 5 μmol ~2.9 mg 342029-95-2 8- (4- [N- Methylanthraniloyl]aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-MABA-cAMP ) M 016-25 5 x 5 μmol 342029-95-2 8- (4- Aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ABA-cAMP ) A 017-05 5 μmol ~2.1 mg 82927-68-2 8- (4- Aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ABA-cAMP ) A 017-25 5 x 5 μmol 82927-68-2 8- (4- Chlorophenylthio)- 2'- O- methyladenosine ( 8-pCPT-2'-O-Me-Ado ) C 070-10 10 μmol ~4.2 mg pending 8- (4- Chlorophenylthio)- 2'- O- methyladenosine ( 8-pCPT-2'-O-Me-Ado ) C 070-50 5 x 10 μmol pending 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cAMP / "007" ) C 041-05 5 μmol ~2.5 mg 510774-50-2 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cAMP / "007" ) C 041-25 5 x 5 μmol 510774-50-2 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-2'-O-Me-cAMP-AM ) C 051-01 1 μmol ~0.6 mg pending 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-2'-O-Me-cAMPS ) C 052-01 1 μmol ~0.5 mg 634208-37-0 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-2'-O-Me-cAMPS ) C 052-05 5 x 1 μmol 634208-37-0 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 5'- O- monophosphate ( 8-pCPT-2'-O-Me-5'-AMP ) C 078-05 5 μmol ~2.5 mg pending 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 5'- O- monophosphate ( 8-pCPT-2'-O-Me-5'-AMP ) C 078-25 5 x 5 μmol pending 8- (4- Chlorophenylthio)- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cGMP ) C 048-05 5 μmol ~2.6 mg 625112-42-7 8- (4- Chlorophenylthio)- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cGMP ) C 048-25 5 x 5 μmol 625112-42-7 8- (4- Chlorophenylthio)- 2'- O- methylxanthosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cXMP ) C 059-05 5 μmol ~2.6 mg pending 8- (4- Chlorophenylthio)- 2'- O- methylxanthosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cXMP ) C 059-25 5 x 5 μmol pending 8- (4- Chlorophenylthio)- N6- phenyladenosine- 3', 5'- cyclic monophosphate ( 8-CPT-6-Phe-cAMP ) C 043-05 5 μmol ~2.8 mg 72549-36-1 8- (4- Chlorophenylthio)- N6- phenyladenosine- 3', 5'- cyclic monophosphate ( 8-CPT-6-Phe-cAMP ) C 043-25 5 x 5 μmol 72549-36-1 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-PET-cGMP ) C 045-05 5 μmol ~3 mg pending 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-PET-cGMP ) C 045-25 5 x 5 μmol pending 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-PET-cGMPS ) C 046-01 1 μmol ~0.6 mg pending 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-PET-cGMPS ) C 046-05 5 x 1 μmol pending 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-PET-cGMPS ) C 047-01 1 μmol ~0.6 mg pending 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-PET-cGMPS ) C 047-05 5 x 1 μmol pending 8- (4- Chlorophenylthio)adenosine ( 8-pCPT-Ado ) C 086-10 10 μmol ~4.1 mg 85352-87-0 8- (4- Chlorophenylthio)adenosine ( 8-pCPT-Ado ) C 086-50 5 x 10 μmol 85352-87-0 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), economy grade C 010-250 E 5 x 50 mg 93882-12-3 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), economy grade C 010-50 E 50 mg ~102 μmol 93882-12-3 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), fluorescence grade C 010-100 100 μmol ~49 mg 93882-12-3 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), fluorescence grade C 010-500 5 x 100 μmol 93882-12-3 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-CPT-cAMP-AM ) C 056-01 1 μmol ~0.5 mg 663941-66-0 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-CPT-cAMP-AM ) C 056-05 5 x 1 μmol 663941-66-0 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-CPT-cAMPS ) C 011-05 5 μmol ~2.5 mg 129735-01-9 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-CPT-cAMPS ) C 011-25 5 x 5 μmol 129735-01-9 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-CPT-cAMPS ) C 012-05 5 μmol ~2.5 mg 129693-13-6 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-CPT-cAMPS ) C 012-25 5 x 5 μmol 129693-13-6 8- (4- Chlorophenylthio)arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-8-pCPT-cAMP ) C 068-05 5 μmol ~2.5 mg pending 8- (4- Chlorophenylthio)arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-8-pCPT-cAMP ) C 068-25 5 x 5 μmol pending 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), economy grade C 009-10 E 10 mg ~19 μmol 51239-26-0 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), economy grade C 009-50 E 5 x 10 mg 51239-26-0 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), fluorescence grade C 009-10 10 μmol ~5 mg 51239-26-0 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), fluorescence grade C 009-50 5 x 10 μmol 51239-26-0 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-cGMP-AM ) C 033-01 1 μmol ~0.6 mg 272445-72-4 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-cGMP-AM ) C 033-05 5 x 1 μmol 272445-72-4 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-cGMPS ) C 013-01 1 μmol ~0.5 mg 153660-04-9 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-cGMPS ) C 013-05 5 x 1 μmol 153660-04-9 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-cGMPS ) C 014-05 5 μmol ~2.6 mg 160385-87-5 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-cGMPS ) C 014-25 5 x 5 μmol 160385-87-5 8- (4- Hydroxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pHPT-2'-O-Me-cAMP ) H 010-05 5 μmol ~2.4 mg 612513-15-2 8- (4- Hydroxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pHPT-2'-O-Me-cAMP ) H 010-25 5 x 5 μmol 612513-15-2 8- (4- Methoxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pMeOPT-2'-O-Me-cAMP ) M 034-05 5 μmol ~2.5 mg 612513-16-3 8- (4- Methoxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pMeOPT-2'-O-Me-cAMP ) M 034-25 5 x 5 μmol 612513-16-3 8- (4- Methoxyphenylthio)adenosine ( 8-pMeOPT-Ado ) M 062-10 10 μmol ~4.0 mg pending 8- (4- Methoxyphenylthio)adenosine ( 8-pMeOPT-Ado ) M 062-50 5 x 10 μmol pending 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-AHA-2'-O-Me-cAMP ) A 099-05 5 μmol 2.3 mg pending 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-AHA-2'-O-Me-cAMP ) A 099-25 5 x 5 μmol pending 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cylic monophosphate, immobilized on agarose ( 8-AHA-2'-O-Me-cAMP-Agarose ) A 057-06 0.6 ml none 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cylic monophosphate, immobilized on agarose ( 8-AHA-2'-O-Me-cAMP-Agarose ) A 057-25 2.5 ml none 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cylic monophosphate, immobilized on agarose ( 8-AHA-2'-O-Me-cAMP-Agarose ) A 057-60 6 ml none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AHA-cAMP ) A 011-10 10 μmol ~4.4 mg 39824-30-1 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AHA-cAMP ) A 011-50 5 x 10 μmol 39824-30-1 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-cAMP Agarose ) A 028-06 0.6 ml none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-cAMP Agarose ) A 028-25 2.5 ml none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-cAMP Agarose ) A 028-60 6 ml none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AHA-cAMPS ) A 085-05 5 μmol ~2.3 mg 214272-02-3 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AHA-cAMPS ) A 085-25 5 x 5 μmol 214272-02-3 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AHA-cAMPS-Agarose ) A 012-06 0.6 ml none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AHA-cAMPS-Agarose ) A 012-25 2.5 ml none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose ( Rp-8-AHA-cAMPS-Agarose ) A 012-60 6 ml none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AHA-cAMPS ) A 071-05 5 μmol ~2.3 mg 214272-03-4 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AHA-cAMPS ) A 071-25 5 x 5 μmol 214272-03-4 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AHA-cAMPS-Agarose ) A 013-06 0.6 ml none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AHA-cAMPS-Agarose ) A 013-25 2.5 ml none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AHA-cAMPS-Agarose ) A 013-60 6 ml none 8- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ADOA-cAMP ) A 033-05 5 μmol ~2.4 mg 214272-05-6 8- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ADOA-cAMP ) A 033-25 5 x 5 μmol 214272-05-6 8- [ Pharos-575]- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-2'-O-Me-cAMP ) P 021-001 0.1 μmol ~74 μg pending 8- [ Pharos-575]- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-2'-O-Me-cAMP ) P 021-005 5 x 0.1 μmol pending 8- [ Pharos-575]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cAMP ) P 019-001 0.1 μmol ~72 μg pending 8- [ Pharos-575]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cAMP ) P 019-005 5 x 0.1 μmol pending 8- [ Pharos-575]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cGMP ) P 020-001 0.1 μmol ~74 μg pending 8- [ Pharos-575]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cGMP ) P 020-005 5 x 0.1 μmol pending 8- [Pharos-450]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cAMP ) P 024-001 0.1 μmol ~72 μg pending 8- [Pharos-450]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cAMP ) P 024-005 5 x 0.1 μmol pending 8- [Pharos-450]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cGMP ) P 025-001 0.1 μmol ~74 μg pending 8- [Pharos-450]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cGMP ) P 025-005 5 x 0.1 μmol pending 8- Aminoadenosine- 5'- O- triphosphate ( 8-NH2-ATP ) A 115-05 5 μmol ~2.6 mg 35874-49-8 8- Aminoadenosine- 5'- O- triphosphate ( 8-NH2-ATP ) A 115-25 5 x 5 μmol 35874-49-8 8- Azido- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-ε-cAMP ) A 077-01 1 μmol ~0.4 mg 60902-12-7 8- Azido- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-ε-cAMP ) A 077-05 5 x 1 μmol 60902-12-7 8- Azido- N6- (2- [DY-547]- aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[DY-547]-AE-cAMP ) A 100-001 0.1 μmol ~0.1 mg pending 8- Azido- N6- (2- [DY-547]- aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[DY-547]-AE-cAMP ) A 100-005 5 x 0.1 μmol pending 8- Azido- N6- (6- [biotinyl]aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[Biotin]-AE-cAMP ) A 127-001 0.1 μmol ~80 μg pending 8- Azido- N6- (6- [biotinyl]aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[Biotin]-AE-cAMP ) A 127-005 5 x 0.1 μmol pending 8- Azidoadenosine ( 8-N3-Ado ) A 045-100 100 μmol ~31 mg 4372-67-2 8- Azidoadenosine ( 8-N3-Ado ) A 045-500 5 x 100 μmol 4372-67-2 8- Azidoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-cAMP ) A 014-10 10 μmol ~3.9 mg 31966-52-6 8- Azidoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-cAMP ) A 014-50 5 x 10 μmol 31966-52-6 8- Azidoadenosine- 5'- O- diphosphate ( 8-N3-ADP ) A 044-05 5 μmol ~2.3 mg 59432-65-4 8- Azidoadenosine- 5'- O- diphosphate ( 8-N3-ADP ) A 044-25 5 x 5 μmol 59432-65-4 8- Azidoadenosine- 5'- O- triphosphate ( 8-N3-ATP ) A 043-05 5 μmol ~2.7 mg 53696-59-6 8- Azidoadenosine- 5'- O- triphosphate ( 8-N3-ATP ) A 043-25 5 x 5 μmol 53696-59-6 8- Benzylthioadenosine- 3', 5'- cyclic monophosphate ( 8-BT-cAMP ) B 015-10 10 μmol ~4.7 mg 50655-17-9 8- Benzylthioadenosine- 3', 5'- cyclic monophosphate ( 8-BT-cAMP ) B 015-50 5 x 10 umol 50655-17-9 8- Bromo- 2'- deoxyadenosine ( 8-Br-dAdo ) B 027-10 10 μmol ~3.3 mg 14985-44-5 8- Bromo- 2'- deoxyadenosine ( 8-Br-dAdo ) B 027-50 5 x 10 μmol 14985-44-5 8- Bromo- 2'- deoxyadenosine- 5'- O- triphosphate ( 8-Br-dATP ) B 069-05 5 μmol ~2.9 mg 92410-99-6 8- Bromo- 2'- deoxyadenosine- 5'- O- triphosphate ( 8-Br-dATP ) B 069-25 5 x 5 μmol 92410-99-6 8- Bromo- 2'- deoxyguanosine ( 8-Br-dGuo ) B 021-10 10 μmol ~3.5 mg 13389-03-2 8- Bromo- 2'- deoxyguanosine ( 8-Br-dGuo ) B 021-50 5 x 10 μmol 13389-03-2 8- Bromo- 2'- deoxyguanosine- 5'- O- triphosphate ( 8-Br-dGTP ) B 070-05 5 μmol ~2.9 mg 66891-23-4 8- Bromo- 2'- deoxyguanosine- 5'- O- triphosphate ( 8-Br-dGTP ) B 070-25 5 x 5 μmol 66891-23-4 8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cAMP ) B 022-05 5 μmol ~2.2 mg 612513-13-0 8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cAMP ) B 022-25 5 x 5 μmol 612513-13-0 8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-2'-O-Me-cAMP-AM ) B 028-01 1 μmol ~0.5 mg pending 8- Bromo- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cGMP ) B 037-05 5 μmol ~1.9 mg pending 8- Bromo- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cGMP ) B 037-25 5 x 5 μmol pending 8- Bromo- 2'- O- monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-MB-cAMPS ) B 010-05 5 μmol ~2.6 mg 788807-32-9 8- Bromo- 2'- O- monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-MB-cAMPS ) B 010-25 5 x 5 μmol 788807-32-9 8- Bromo- cyclic adenosine diphosphate ribose ( 8-Br-cADPR ) B 065-005 0.5 μmol ~310 μg 151898-26-9 8- Bromo- cyclic adenosine diphosphate ribose ( 8-Br-cADPR ) B 065-025 5 x 0.5 μmol 151898-26-9 8- Bromo- cyclic inosine diphosphate ribose ( 8-Br-N1-cIDPR ) B 071-005 0.5 μmol 311 μg 638195-70-7 8- Bromo- cyclic inosine diphosphate ribose ( 8-Br-N1-cIDPR ) B 071-025 5 x 0.5 μmol 638195-70-7 8- Bromo- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-PET-cGMPS ) P 007-01 1 μmol ~0.6 mg 172806-20-1 8- Bromo- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-PET-cGMPS ) P 007-05 5 x 1 μmol 172806-20-1 8- Bromo- β -phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-PET-cGMPS ) P 008-05 5 μmol ~2.8 mg 172806-21-2 8- Bromo- β -phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-PET-cGMPS ) P 008-25 5 x 5 μmol 172806-21-2 8- Bromoadenine ( 8-Br-Ade ) B 052-10 10 μmol ~2.1 mg 6974-78-3 8- Bromoadenine ( 8-Br-Ade ) B 052-50 5 x 10 μmol 6974-78-3 8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), economy grade B 007-250 E 5 x 50 mg 76939-46-3 8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), economy grade B 007-50 E 50 mg ~116 μmol 76939-46-3 8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), fluorescence grade B 007-100 100 μmol ~43 mg 76939-46-3 8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), fluorescence grade B 007-500 5 x 100 μmol 76939-46-3 8- Bromoadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cAMP-AM ) B 020-01 1 μmol ~0.5 mg 190522-24-8 8- Bromoadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cAMP-AM ) B 020-05 5 x 1 μmol 190522-24-8 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, acetoxymethyl ester, Sp- isomer ( Sp-8-Br-cAMPS-AM ) B 029-01 1 μmol ~0.5 mg pending 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, acetoxymethyl ester, Sp- isomer ( Sp-8-Br-cAMPS-AM ) B 029-05 5 x 1 μmol pending 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cAMPS ) B 001-05 5 μmol ~2.2 mg 129735-00-8 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cAMPS ) B 001-25 5 x 5 μmol 129735-00-8 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cAMPS ) B 002-05 5 μmol ~2.2 mg 127634-20-2 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cAMPS ) B 002-25 5 x 5 μmol 127634-20-2 8- Bromoadenosine- 5'- O- diphosphate ( 8-Br-ADP ) B 067-05 5 μmol ~2.5 mg 23600-16-0 8- Bromoadenosine- 5'- O- diphosphate ( 8-Br-ADP ) B 067-25 5 x 5 μmol 23600-16-0 8- Bromoadenosine- 5'- O- diphosphoribose ( 8-Br-ADPR ), sodium salt B 051-05 5 μmol ~3.2 mg 59259-77-7 8- Bromoadenosine- 5'- O- diphosphoribose ( 8-Br-ADPR ), sodium salt B 051-25 5 x 5 μmol 59259-77-7 8- Bromoadenosine- 5'- O- monophosphate ( 8-Br-5'-AMP ) B 066-10 10 μmol ~4.3 mg 23567-96-6 8- Bromoadenosine- 5'- O- monophosphate ( 8-Br-5'-AMP ) B 066-50 5 x 10 μmol 23567-96-6 8- Bromoadenosine- 5'- O- triphosphate ( 8-Br-ATP ) B 068-05 5 μmol ~2.9 mg 23567-97-7 8- Bromoadenosine- 5'- O- triphosphate ( 8-Br-ATP ) B 068-25 5 x 5 μmol 23567-97-7 8- Bromoguanine ( 8-Br-Gua ) B 058-10 10 μmol ~2.3 mg 3066-84-0 8- Bromoguanine ( 8-Br-Gua ) B 058-50 5 x 10 μmol 3066-84-0 8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), economy grade B 004-250 E 5 x 50 mg 51116-01-9 8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), economy grade B 004-50 E 50 mg ~111 μmol 51116-01-9 8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), fluorescence grade B 004-250 5 x 50 μmol 51116-01-9 8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), fluorescence grade B 004-50 50 μmol ~22 mg 51116-01-9 8- Bromoguanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cGMP-AM ) B 014-01 1 μmol ~0.5 mg 272445-71-3 8- Bromoguanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cGMP-AM ) B 014-05 5 x 1 μmol 272445-71-3 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cGMPS ) B 005-05 5 μmol ~2.3 mg 150418-07-8 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cGMPS ) B 005-25 5 x 5 μmol 150418-07-8 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cGMPS ) B 006-10 10 μmol ~4.6 mg 153660-03-8 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cGMPS ) B 006-50 5 x 10 μmol 153660-03-8 8- Bromoguanosine- 5'- O- monophosphate ( 8-Br-5'-GMP ) B 057-10 10 μmol ~4.4 mg 21870-09-7 8- Bromoguanosine- 5'- O- monophosphate ( 8-Br-5'-GMP ) B 057-50 5 x 10 μmol 21870-09-7 8- Bromoguanosine- 5'- O- triphosphate ( 8-Br-GTP ) B 012-05 5 μmol ~3 mg 23197-98-0 8- Bromoguanosine- 5'- O- triphosphate ( 8-Br-GTP ) B 012-25 5 x 5 μmol 23197-98-0 8- Bromoinosine- 5'- O- diphosphoribose ( 8-Br-IDPR ), sodium salt B 082-005 0.5 μmol ~320 μg pending 8- Bromoinosine- 5'- O- diphosphoribose ( 8-Br-IDPR ), sodium salt B 082-025 5 x 0.5 μmol pending 8- Bromo-ß-phenyl- 1, N²- ethenoguanosine- 3', 5'-cyclic monophosphate ( 8-Br-PET-cGMP ) P 003-10 10 μmol ~5.5 mg 144510-04-3 8- Bromo-ß-phenyl- 1, N²- ethenoguanosine- 3', 5'-cyclic monophosphate ( 8-Br-PET-cGMP ) P 003-50 5 x 10 μmol 144510-04-3 8- Carboxyethylaminoadenosine ( 8-CEA-Ado ) C 092-10 10 μmol ~3.5 mg pending 8- Carboxyethylaminoadenosine ( 8-CEA-Ado ) C 092-50 5 x 10 μmol pending 8- Chloro- 2'- deoxyadenosine ( 8-Cl-d-Ado ) C 024-05 5 μmol ~1.4 mg 85562-55-6 8- Chloro- 2'- deoxyadenosine ( 8-Cl-d-Ado ) C 024-25 5 x 5 μmol 85562-55-6 8- Chloro- 2'- deoxyguanosine ( 8-Cl-dGuo ) C 025-05 5 μmol ~1.5 mg 437715-62-3 8- Chloro- 2'- deoxyguanosine ( 8-Cl-dGuo ) C 025-25 5 x 5 μmol 437715-62-3 8- Chloroadenine ( 8-Cl-Ade ) C 023-10 10 μmol ~1.7 mg 28128-28-1 8- Chloroadenine ( 8-Cl-Ade ) C 023-50 5 x 10 μmol 28128-28-1 8- Chloroadenosine ( 8-Cl-Ado ) C 006-10 10 μmol ~3 mg 34408-14-5 8- Chloroadenosine ( 8-Cl-Ado ) C 006-50 5 x 10 μmol 34408-14-5 8- Chloroadenosine- 3', 5'- cyclic monophosphate ( 8-Cl-cAMP ) C 007-10 10 μmol ~3.9 mg 41941-56-4 8- Chloroadenosine- 3', 5'- cyclic monophosphate ( 8-Cl-cAMP ) C 007-50 5 x 10 μmol 41941-56-4 8- Chloroadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Cl-cAMP-AM ) C 050-01 1 μmol ~0.4 mg pending 8- Chloroadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Cl-cAMP-AM ) C 050-05 5 x 1 μmol pending 8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Cl-cAMPS ) C 003-05 5 μmol ~2 mg 142754-27-6 8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Cl-cAMPS ) C 003-25 5 x 5 μmol 142754-27-6 8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Cl-cAMPS ) C 004-05 5 μmol ~2 mg 142754-28-7 8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Cl-cAMPS ) C 004-25 5 x 5 μmol 142754-28-7 8- Chloroadenosine- 5'- O- diphosphate ( 8-Cl-5'-ADP ) C 042-05 5 μmol ~2.3 mg 185341-69-9 8- Chloroadenosine- 5'- O- diphosphate ( 8-Cl-5'-ADP ) C 042-25 5 x 5 μmol 185341-69-9 8- Chloroadenosine- 5'- O- monophosphate ( 8-Cl-5'-AMP ) C 016-05 5 μmol ~1.9 mg 37676-40-7 8- Chloroadenosine- 5'- O- monophosphate ( 8-Cl-5'-AMP ) C 016-25 5 x 5 μmol 37676-40-7 8- Chloroadenosine- 5'- O- triphosphate ( 8-Cl-ATP ) C 018-05 5 μmol ~2.7 mg 185341-71-3 8- Chloroadenosine- 5'- O- triphosphate ( 8-Cl-ATP ) C 018-25 5 x 5 μmol 185341-71-3 8- Chloroguanine ( 8-Cl-Gua ) C 027-10 10 μmol ~1.9 mg 22052-03-5 8- Chloroguanine ( 8-Cl-Gua ) C 027-50 5 x 10 μmol 22052-03-5 8- Chloroguanosine ( 8-Cl-Guo ) C 026-05 5 μmol ~1.6 mg 2104-68-9 8- Chloroguanosine ( 8-Cl-Guo ) C 026-25 5 x 5 μmol 2104-68-9 8- Chloroinosine ( 8-Cl-Ino ) C 019-05 5 μmol ~1.5 mg 116285-77-9 8- Chloroinosine ( 8-Cl-Ino ) C 019-25 5 x 5 μmol 116285-77-9 8- Chloroxanthine ( 8-Cl-X ) C 044-10 10 μmol ~1.9 mg 13548-68-0 8- Chloroxanthine ( 8-Cl-X ) C 044-50 5 x 10 μmol 13548-68-0 8- Hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 8-HA-cAMP ) H 006-05 5 μmol ~2.3 mg 59212-44-1 8- Hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 8-HA-cAMP ) H 006-25 5 x 5 μmol 59212-44-1 8- Hydroxy- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-OH-2'-O-Me-cAMP ) H 013-05 5 μmol ~1.9 mg pending 8- Hydroxy- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-OH-2'-O-Me-cAMP ) H 013-25 5 x 5 μmol pending 8- Hydroxyadenine ( 8-OH-Ade ) H 007-100 100 μmol ~15 mg 21149-26-8 8- Hydroxyadenine ( 8-OH-Ade ) H 007-500 5 x 100 μmol 21149-26-8 8- Hydroxyadenosine ( 8-OH-Ado ) H 011-05 5 μmol ~1.4 mg 29851-57-8 8- Hydroxyadenosine ( 8-OH-Ado ) H 011-25 5 x 5 μmol 29851-57-8 8- Hydroxyadenosine- 3', 5'- cyclic monophosphate ( 8-OH-cAMP ) H 003-05 5 μmol ~1.8 mg 31356-95-3 8- Hydroxyadenosine- 3', 5'- cyclic monophosphate ( 8-OH-cAMP ) H 003-25 5 x 5 μmol 31356-95-3 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-OH-cAMPS ) H 004-01 1 μmol ~0.4 mg 755748-37-9 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-OH-cAMPS ) H 004-05 5 x 1 μmol 755748-37-9 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-OH-cAMPS ) H 005-05 5 μmol ~1.9 mg 749843-87-6 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-OH-cAMPS ) H 005-25 5 x 5 μmol 749843-87-6 8- Hydroxyguanine ( 8-OH-Gua ) H 002-100 100 μmol ~17 mg 5614-64-2 8- Hydroxyguanine ( 8-OH-Gua ) H 002-500 5 x 100 μmol 5614-64-2 8- Hydroxyguanosine ( 8-OH-Guo ) H 001-05 5 μmol ~1.5 mg 3868-31-3 8- Hydroxyguanosine ( 8-OH-Guo ) H 001-25 5 x 5 μmol 3868-31-3 8- Methylaminoadenosine- 3', 5' cyclic monophosphate ( 8-MA-cAMP ) M 001-10 10 μmol ~3.8 mg 33823-18-6 8- Methylaminoadenosine- 3', 5' cyclic monophosphate ( 8-MA-cAMP ) M 001-50 5 x 10 μmol 33823-18-6 8- Nitroguanine ( 8-NO2-Gua ) N 003-05 5 μmol ~1 mg 168701-80-2 8- Nitroguanine ( 8-NO2-Gua ) N 003-25 5 x 5 μmol 168701-80-2 8- Nitroguanosine ( 8-NO2-Guo ) N 004-05 5 μmol ~1.6 mg 337536-53-5 8- Nitroguanosine ( 8-NO2-Guo ) N 004-25 5 x 5 μmol 337536-53-5 8- Phenylthioadenosine ( 8-PT-Ado ) P 032-10 10 μmol ~3.8 mg pending 8- Phenylthioadenosine ( 8-PT-Ado ) P 032-50 5 x 10 μmol pending 8- Piperidinoadenosine- 3', 5'- cyclic monophosphate ( 8-PIP-cAMP ) P 002-10 10 μmol ~4.3 mg 31357-06-9 8- Piperidinoadenosine- 3', 5'- cyclic monophosphate ( 8-PIP-cAMP ) P 002-50 5 x 10 μmol 31357-06-9 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-PIP-cAMPS ) P 004-05 5 μmol ~2.3 mg 156816-36-3 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-PIP-cAMPS ) P 004-25 5 x 5 μmol 156816-36-3 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-PIP-cAMPS ) P 005-05 5 μmol ~2.3 mg 156816-35-2 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-PIP-cAMPS ) P 005-25 5 x 5 μmol 156816-35-2 Adenosine- 1- N- oxid- 3', 5'- cyclic monophosphate A 023-05 5 μmol ~1.8 mg 75912-25-3 Adenosine- 1- N- oxid- 3', 5'- cyclic monophosphate A 023-25 5 x 5 μmol 75912-25-3 Adenosine- 2', 3'- cyclic monophosphorothioate, Rp- / endo isomer ( Rp-2',3'-cAMPS ) A 006-05 5 μmol ~1.9 mg 118275-99-3 Adenosine- 2', 3'- cyclic monophosphorothioate, Rp- / endo isomer ( Rp-2',3'-cAMPS ) A 006-25 5 x 5 μmol 118275-99-3 Adenosine- 2', 3'- cyclic monophosphorothioate, Sp- / exo isomer ( Sp-2',3'-cAMPS ) A 024-05 5 μmol ~1.9 mg 118276-00-9 Adenosine- 2', 3'- cyclic monophosphorothioate, Sp- / exo isomer ( Sp-2',3'-cAMPS ) A 024-25 5 x 5 μmol 118276-00-9 Adenosine- 3' ,5'- cyclic monophosphate ( cAMP ), free acid form A 001-2500 H 5 x 500 mg 60-92-4 Adenosine- 3' ,5'- cyclic monophosphate ( cAMP ), free acid form A 001-500 H 500 mg ~1.5 mmol 60-92-4 Adenosine- 3', 5'- cyclic monophosphate ( cAMP ), sodium salt A 001-2500 5 x 500 μmol 37839-81-9 Adenosine- 3', 5'- cyclic monophosphate ( cAMP ), sodium salt A 001-500 500 μmol ~176 mg 37839-81-9 Adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cAMP-AM ) A 022-01 1 μmol ~0.4 mg 159764-93-9 Adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cAMP-AM ) A 022-05 5 x 1 μmol 159764-93-9 Adenosine- 3', 5'- cyclic monophosphate, benzyl ester ( cAMP-Bn ) A 065-01 1 μmol ~0.4 mg 62742-71-6 Adenosine- 3', 5'- cyclic monophosphate, benzyl ester ( cAMP-Bn ) A 065-05 5 x 1 μmol 62742-71-6 Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), economy grade A 002-05 T 5 μmol ~2.2 mg 151837-09-1 Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), economy grade A 002-25 T 5 x 5 μmol 151837-09-1 Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), high purity grade A 002-05 S 5 μmol ~1.8 mg 73208-40-9 Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), high purity grade A 002-25 S 5 x 5 μmol 73208-40-9 Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ) A 003-10 T 10 μmol ~4.5 mg 93602-66-5 Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ) A 003-50 T 5 x 10 μmol 93602-66-5 Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ), high purity grade A 003-10 S 10 μmol ~3.7 mg 71774-13-5 Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ), high purity grade A 003-50 S 5 x 10 μmol 71774-13-5 Adenosine- 3', 5'- monophosphorothioate acetoxymethyl ester, Sp- isomer ( Sp-cAMPS-AM ) A 035-01 1 μmol ~0.4 mg 152218-24-1 Adenosine- 3', 5'- monophosphorothioate acetoxymethyl ester, Sp- isomer ( Sp-cAMPS-AM ) A 035-05 5 x 1 μmol 152218-24-1 Adenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-ADP-α-S ) A 037-05 5 μmol ~2.2 mg 59331-71-4 Adenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-ADP-α-S ) A 037-25 5 x 5 μmol 59331-71-4 Adenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-ADP-α-S ) A 038-05 5 μmol ~2.2 mg 59286-20-3 Adenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-ADP-α-S ) A 038-25 5 x 5 μmol 59286-20-3 Adenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-ATP-α-S ) A 039-05 5 μmol ~2.6 mg 58976-49-1 Adenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-ATP-α-S ) A 039-25 5 x 5 μmol 58976-49-1 Adenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-ATP-α-S ) A 040-05 5 μmol ~2.6 mg 35094-46-3 Adenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-ATP-α-S ) A 040-25 5 x 5 μmol 35094-46-3 Adenosine- 5'- O- (2- thiodiphosphate) ( ADP-β-S ) A 121-05 5 μmol ~2.2 mg 35094-45-2 Adenosine- 5'- O- (2- thiodiphosphate) ( ADP-β-S ) A 121-25 5 x 5 μmol 35094-45-2 Adenosine- 5'- O- (3- thiotriphosphate) ( ATP-γ-S ) A 060-05 5 μmol ~2.6 mg 93839-89-5 Adenosine- 5'- O- (3- thiotriphosphate) ( ATP-γ-S ) A 060-25 5 x 5 μmol 93839-89-5 Adenosine- 5'- O- (α, β- methylenediphosphate) ( AMP-CP / AOPCP ) A 070-05 5 μmol ~2.1 mg 104835-70-3 Adenosine- 5'- O- (α, β- methylenediphosphate) ( AMP-CP / AOPCP ) A 070-25 5 x 5 μmol 104835-70-3 Adenosine- 5'- O- monophosphorothioate ( 5'- AMPS ) A 005-250 5 x 50 μmol 93839-85-1 Adenosine- 5'- O- monophosphorothioate ( 5'- AMPS ) A 005-50 50 μmol ~18 mg 93839-85-1 Adenosine- 5'- O- phosphosulfate ( APS ) A 061-10 10 μmol ~4.3 mg 102029-95-8 Adenosine- 5'- O- phosphosulfate ( APS ) A 061-50 5 x 10 μmol 102029-95-8 Arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-cAMP ) A 076-05 5 μmol ~1.8 mg 32465-18-2 Arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-cAMP ) A 076-25 5 x 5 μmol 32465-18-2 beta- (4- Azidophenyl)- 1, N2- etheno- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( 4-N3-PET-8-Br-cGMP ) A 102-01 1 μmol ~0.6 mg pending beta- (4- Azidophenyl)- 1, N2- etheno- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( 4-N3-PET-8-Br-cGMP ) A 102-05 5 x 1 μmol pending beta- Nicotinamide- 1, N6- ethenoadenine dinucleotide ( ε-NAD+ ) N 010-10 10 μmol ~6.9 mg 38806-38-1 beta- Nicotinamide- 1, N6- ethenoadenine dinucleotide ( ε-NAD+ ) N 010-50 5 x 10 μmol 38806-38-1 beta- Nicotinamide- N6- (2- (6- [biotinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Biotin-17-NAD+ ), sodium salt N 012-001 0.1 μmol ~0.12 mg pending beta- Nicotinamide- N6- (2- (6- [biotinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Biotin-17-NAD+ ), sodium salt N 012-005 5 x 0.1 μmol pending beta- Nicotinamide- N6- (2- aminoethyl)adenine dinucleotide ( 6-AE-NAD+ ), sodium salt N 013-05 5 μmol ~3.5 mg 59587-50-7 beta- Nicotinamide- N6- (2- aminoethyl)adenine dinucleotide ( 6-AE-NAD+ ), sodium salt N 013-25 5 x 5 μmol 59587-50-7 beta- Phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( PET-cGMP ) P 001-10 10 μmol ~4.7 mg 78080-27-0 beta- Phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( PET-cGMP ) P 001-50 5 x 10 μmol 78080-27-0 Cyclic adenosine diphosphate ribose ( cADPR ) C 005-005 0.5 μmol ~270 μg 119340-53-3 Cyclic adenosine diphosphate ribose ( cADPR ) C 005-025 5 x 0.5 μmol 119340-53-3 Cyclic diadenosine monophosphate ( c-diAMP ) / cyclic bis ( 3' → 5' ) diadenylic acid, sodium salt C 088-001 0.1 μmol ~66 μg 54447-84-6 Cyclic diadenosine monophosphate ( c-diAMP ) / cyclic bis ( 3' → 5' ) diadenylic acid, sodium salt C 088-005 5 x 0.1 μmol 54447-84-6 Cyclic diguanosine monophosphate ( c-diGMP ) / cyclic bis ( 3' → 5' ) diguanylic acid C 057-001 0.1 μmol ~69 μg 61093-23-0 Cyclic diguanosine monophosphate ( c-diGMP ) / cyclic bis ( 3' → 5' ) diguanylic acid C 057-005 5 x 0.1 μmol 61093-23-0 Cyclic inosine diphosphate ribose ( N1-cIDPR ), sodium salt C 098-005 0.5 μmol ~271 μg 856702-89-1 Cyclic inosine diphosphate ribose ( N1-cIDPR ), sodium salt C 098-025 5 x 0.5 μmol 856702-89-1 Cytidine- 3', 5'- cyclic monophosphate ( cCMP ) C 001-250 5 x 50 μmol 54925-33-6 Cytidine- 3', 5'- cyclic monophosphate ( cCMP ) C 001-50 50 μmol ~16 mg 54925-33-6 Cytidine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cCMP-AM ) C 067-01 1 μmol ~0.4 mg pending Cytidine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cCMP-AM ) C 067-05 5 x 1 μmol pending Cytidine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cCMPS ) C 065-01 1 μmol ~0.3 mg 87063-79-4 Cytidine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cCMPS ) C 065-05 5 x 1 μmol 87063-79-4 Cytidine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cCMPS ) C 066-05 5 μmol ~1.7 mg 87063-81-8 Cytidine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cCMPS ) C 066-25 5 x 5 μmol 87063-81-8 Cytidine- 5'- O- (2- thiodiphosphate) ( CDP-β-S ) C 079-05 5 μmol ~2.1 mg 497064-72-9 Cytidine- 5'- O- (2- thiodiphosphate) ( CDP-β-S ) C 079-25 5 x 5 μmol 497064-72-9 Cytidine- 5'- O- (α, β- methylene)diphosphate ( CMP-CP ) C 077-05 5 μmol ~2 mg 101536-15-6 Cytidine- 5'- O- (α, β- methylene)diphosphate ( CMP-CP ) C 077-25 5 x 5 μmol 101536-15-6 Cytidine- 5'- O- monophosphorothioate ( 5'-CMPS ) C 053-05 5 μmol ~1.7 mg 47151-76-8 Cytidine- 5'- O- monophosphorothioate ( 5'-CMPS ) C 053-25 5 x 5 μmol 47151-76-8 Ethanolamine immobilized on agarose ( EtOHNH2-Agarose ) E 010-06 0.6 ml pending Ethanolamine immobilized on agarose ( EtOHNH2-Agarose ) E 010-25 2.5 ml pending Ethanolamine immobilized on agarose ( EtOHNH2-Agarose ) E 010-60 6 ml pending Guanosine- 2', 3'- cyclic monophosphate ( 2',3'-cGMP ), sodium salt G 025-250 5 x 50 μmol 15718-49-7 Guanosine- 2', 3'- cyclic monophosphate ( 2',3'-cGMP ), sodium salt G 025-50 50 μmol ~18 mg 15718-49-7 Guanosine- 3', 5'- cyclic monophosphate ( cGMP ) G 001-100 100 μmol ~37 mg 40732-48-7 Guanosine- 3', 5'- cyclic monophosphate ( cGMP ) G 001-500 5 x 100 μmol 40732-48-7 Guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cGMP-AM ) G 002-01 1 μmol ~0.4 mg 164007-71-0 Guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cGMP-AM ) G 002-05 5 x 1 μmol 164007-71-0 Guanosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer ( Rp- cGMPS ) G 016-05 5 μmol ~1.9 mg 86562-09-6 Guanosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer ( Rp- cGMPS ) G 016-25 5 x 5 μmol 86562-09-6 Guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cGMPS ) G 017-05 5 μmol ~1.9 mg 86562-10-9 Guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cGMPS ) G 017-25 5 x 5 μmol 86562-10-9 Guanosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-GDP-α-S ) G 012-05 5 μmol ~2.3 mg 71481-44-2 Guanosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-GDP-α-S ) G 012-25 5 x 5 μmol 71481-44-2 Guanosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-GDP-α-S ) G 013-05 5 μmol ~2.3 mg 71481-45-3 Guanosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-GDP-α-S ) G 013-25 5 x 5 μmol 71481-45-3 Guanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-GTP-α-S ) G 014-05 5 μmol ~2.7 mg 81570-50-5 Guanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-GTP-α-S ) G 014-25 5 x 5 μmol 81570-50-5 Guanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-GTP-α-S ) G 015-05 5 μmol ~2.7 mg 81570-51-6 Guanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-GTP-α-S ) G 015-25 5 x 5 μmol 81570-51-6 Guanosine- 5'- O- (2- thiodiphosphate) ( GDP-β-S ) G 023-05 5 μmol ~2.3 mg 71376-97-1 Guanosine- 5'- O- (2- thiodiphosphate) ( GDP-β-S ) G 023-25 5 x 5 μmol 71376-97-1 Guanosine- 5'- O- (3- thiotriphosphate) ( GTP-γ-S ) G 019-05 5 μmol ~2.7 mg 37589-80-3 Guanosine- 5'- O- (3- thiotriphosphate) ( GTP-γ-S ) G 019-25 5 x 5 μmol 37589-80-3 Guanosine- 5'- O- (α, β- methylene)diphosphate ( GMP-CP ) G 024-05 5 μmol ~2.2 mg 32381-15-0 Guanosine- 5'- O- (α, β- methylene)diphosphate ( GMP-CP ) G 024-25 5 x 5 μmol 32381-15-0 Guanosine- 5'- O- monophosphorothioate ( 5'-GMPS ) G 018-10 10 μmol ~3.8 mg 76310-16-2 Guanosine- 5'- O- monophosphorothioate ( 5'-GMPS ) G 018-50 5 x 10 μmol 76310-16-2 Inosine- 3', 5'- cyclic monophosphate ( cIMP ) I 001-250 5 x 50 μmol 41092-64-2 Inosine- 3', 5'- cyclic monophosphate ( cIMP ) I 001-50 50 μmol ~18 mg 41092-64-2 Ko-Libri Library of Nucleosides and Nucleobases K 001-48 48 x 250 μl pending N1- Aminoguanosine- 3', 5'- cyclic monophosphate ( 1-NH2-cGMP ) A 041-05 5 μmol ~1.9 mg 78033-42-8 N1- Aminoguanosine- 3', 5'- cyclic monophosphate ( 1-NH2-cGMP ) A 041-25 5 x 5 μmol 78033-42-8 N2- (6- [ Biotinyl]aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-[Biotin]-AH-cGMP ) B 032-01 1 μmol ~0.8 mg pending N2- (6- [ Biotinyl]aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-[Biotin]-AH-cGMP ) B 032-05 5 x 1 μmol pending N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-AH-cGMP ) A 055-05 5 μmol ~2.2 mg 205368-58-7 N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-AH-cGMP ) A 055-25 5 x 5 μmol 205368-58-7 N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AH-cGMP Agarose ) A 056-06 0.6 ml none N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AH-cGMP Agarose ) A 056-25 2.5 ml none N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose ( 2-AH-cGMP Agarose ) A 056-60 6 ml none N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate ( DB-cGMP ) D 010-250 5 x 50 μmol 51116-00-8 N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate ( DB-cGMP ) D 010-50 50 μmol ~25 mg 51116-00-8 N², N²- Dimethylguanosine ( M²2Guo ) D 016-100 100 μmol ~31 mg 2140-67-2 N², N²- Dimethylguanosine ( M²2Guo ) D 016-500 5 x 100 μmol 2140-67-2 N2, N2, 7- Trimethylguanosine ( m2,2,7G / TMG ) T 009-05 5 μmol ~1.9 mg 40027-70-1 N2, N2, 7- Trimethylguanosine ( m2,2,7G / TMG ) T 009-25 5 x 5 μmol 40027-70-1 N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate ( DB-cCMP ) D 075-10 10 μmol ~4.7 mg 64649-87-2 N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate ( DB-cCMP ) D 075-50 5 x 10 μmol 64649-87-2 N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-1MeBu-ADP ) M 026-05 5 μmol ~2.5 mg pending N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-1MeBu-ADP ) M 026-25 5 x 5 μmol pending N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-1MeBu-ATP ) M 027-05 5 μmol ~2.9 mg 252889-13-7 N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-1MeBu-ATP ) M 027-25 5 x 5 μmol 252889-13-7 N6- (2- Aminoethyl)- 8- azidoadenosine- 3', 5'- cyclic monophosphate ( 6-AE-8-N3-cAMP ) A 101-01 1 μmol ~0.4 mg pending N6- (2- Aminoethyl)- 8- azidoadenosine- 3', 5'- cyclic monophosphate ( 6-AE-8-N3-cAMP ) A 101-05 5 x 1 μmol pending N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AE-cAMP ) A 096-05 5 μmol ~1.9 mg 66311-08-8 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AE-cAMP ) A 096-25 5 x 5 μmol 66311-08-8 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AE-cAMP-Agarose ) A 111-06 0.6 ml none N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AE-cAMP-Agarose ) A 111-25 2.5 ml none N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AE-cAMP-Agarose ) A 111-60 6 ml none N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AE-cAMPS ) A 092-05 5 μmol ~1.9 mg pending N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AE-cAMPS ) A 092-25 5 x 5 μmol pending N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AE-cAMPS-Agarose ) A 109-06 0.6 ml none N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AE-cAMPS-Agarose ) A 109-25 2.5 ml none N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AE-cAMPS-Agarose ) A 109-60 6 ml none N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-2MeBu-ADP ) M 028-05 5 μmol ~2.5 mg 681175-77-9 N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-2MeBu-ADP ) M 028-25 5 x 5 μmol 681175-77-9 N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-2MeBu-ATP ) M 029-05 5 μmol ~2.9 mg 252889-14-8 N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-2MeBu-ATP ) M 029-25 5 x 5 μmol 252889-14-8 N6- (2- Phenylethyl)adenosine- 5'- O- (3- thiotriphosphate) ( 6-PhEt-ATP-γ-S ) P 026-05 5 μmol ~3.1 mg pending N6- (2- Phenylethyl)adenosine- 5'- O- (3- thiotriphosphate) ( 6-PhEt-ATP-γ-S ) P 026-25 5 x 5 μmol pending N6- (3- [([Biotinyl]- 3- aminopropoxy(ethoxy)ethoxy)ethoxy]ethoxypropyl)adenosine- 5'- O- diphosphate ( 6-Biotin-APrO-(EO)4-Pr-ADP ), sodium salt B 077-01 1 μmol ~1 mg pending N6- (3- [([Biotinyl]- 3- aminopropoxy(ethoxy)ethoxy)ethoxy]ethoxypropyl)adenosine- 5'- O- diphosphate ( 6-Biotin-APrO-(EO)4-Pr-ADP ), sodium salt B 077-05 5 x 1 μmol pending N6- (3- [Biotinyl]aminopropyl)adenosine- 5'- O- diphosphate ( 6-Biotin-APr-ADP ), sodium salt B 076-01 1 μmol 0.7 mg N6- (3- [Biotinyl]aminopropyl)adenosine- 5'- O- diphosphate ( 6-Biotin-APr-ADP ), sodium salt B 076-25 5 x 1 μmol pending N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3MeBn)-ADP ) M 024-05 5 μmol ~2.7 mg 681175-78-0 N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3MeBn)-ADP ) M 024-25 5 x 5 μmol 681175-78-0 N6- (3- Methylbenzyl)adenosine- 5'- O- triphosphate ( 6-(3MeBn)-ATP ) M 025-05 5 μmol ~3.1 mg 215321-95-2 N6- (3- Methylbenzyl)adenosine- 5'- O- triphosphate ( 6-(3MeBn)-ATP ) M 025-25 5 x 5 μmol 215321-95-2 N6- (4- Aminobutyl)adenosine- 5'- O- diphosphate ( 6-AB-ADP ) A 026-05 5 μmol ~2.5 mg 767272-34-4 N6- (4- Aminobutyl)adenosine- 5'- O- diphosphate ( 6-AB-ADP ) A 026-25 5 x 5 μmol 767272-34-4 N6- (4- Aminobutyl)adenosine- 5'- O- triphosphate ( 6-AB-ATP ) A 074-05 5 μmol ~2.9 mg 280577-98-2 N6- (4- Aminobutyl)adenosine- 5'- O- triphosphate ( 6-AB-ATP ) A 074-25 5 x 5 μmol 280577-98-2 N6- (6- [N- Methylanthraniloyl]hexylamino)adenosine-3', 5'- cyclic monophosphate ( 6-MAH-cAMP ) M 017-05 5 μmol ~2.9 mg 723313-27-7 N6- (6- [N- Methylanthraniloyl]hexylamino)adenosine-3', 5'- cyclic monophosphate ( 6-MAH-cAMP ) M 017-25 5 x 5 μmol 723313-27-7 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AH-cAMP ) A 031-05 5 μmol ~2.1 mg 66311-09-9 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AH-cAMP ) A 031-25 5 x 5 μmol 66311-09-9 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AH-cAMP Agarose ) A 036-06 0.6 ml none N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AH-cAMP Agarose ) A 036-25 2.5 ml none N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AH-cAMP Agarose ) A 036-60 6 ml none N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AH-cAMPS ) A 089-05 5 μmol ~2.2 mg pending N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AH-cAMPS ) A 089-25 5 x 5 μmol pending N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AH-cAMPS-Agarose ) A 108-06 0.6 ml none N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AH-cAMPS-Agarose ) A 108-25 2.5 ml none N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AH-cAMPS-Agarose ) A 108-60 6 ml none N6- Benzoyladenosine- 3', 5'- cyclic monophosphate ( 6-Bnz-cAMP ) B 009-10 10 μmol ~4.6 mg 30275-80-0 N6- Benzoyladenosine- 3', 5'- cyclic monophosphate ( 6-Bnz-cAMP ) B 009-50 5 x 10 μmol 30275-80-0 N6- Benzoyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 6-Bnz-cAMP-AM ) B 079-01 1 μmol ~0.5 mg [pending] N6- Benzoyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 6-Bnz-cAMP-AM ) B 079-05 5 x 1 μmol [pending] N6- Benzoyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Bnz-cAMPS ) B 040-05 5 μmol ~2.4 mg 152218-18-3 N6- Benzoyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Bnz-cAMPS ) B 040-25 5 x 5 μmol 152218-18-3 N6- Benzyladenosine- 3', 5'- cyclic monophosphate ( 6-Bn-cAMP ) B 008-10 10 μmol ~4.4 mg 32115-08-5 N6- Benzyladenosine- 3', 5'- cyclic monophosphate ( 6-Bn-cAMP ) B 008-50 5 x 10 μmol 32115-08-5 N6- Benzyladenosine- 5'- O- (3- thiotriphosphate) ( 6-Bn-ATP-γ-S ) B 072-05 5 μmol ~3.1 mg pending N6- Benzyladenosine- 5'- O- (3- thiotriphosphate) ( 6-Bn-ATP-γ-S ) B 072-25 5 x 5 μmol pending N6- Benzyladenosine- 5'- O- diphosphate ( 6-Bn-ADP ) B 023-05 5 μmol ~2.6 mg 40811-89-0 N6- Benzyladenosine- 5'- O- diphosphate ( 6-Bn-ADP ) B 023-25 5 x 5 μmol 40811-89-0 N6- Benzyladenosine- 5'- O- triphosphate ( 6-Bn-ATP ) B 024-05 5 μmol ~3 mg 40922-97-2 N6- Benzyladenosine- 5'- O- triphosphate ( 6-Bn-ATP ) B 024-25 5 x 5 μmol 40922-97-2 N6- Carbamoylthreonyladenosine ( t6-Ado ) C 022-10 10 μmol ~4.3 mg 24719-82-2 N6- Carbamoylthreonyladenosine ( t6-Ado ) C 022-50 5 x 10 μmol 24719-82-2 N6- Cyclohexyladenosine- 5'- O- diphosphate ( 6-cHe-ADP ) C 085-05 5 μmol ~2.5 mg pending N6- Cyclohexyladenosine- 5'- O- diphosphate ( 6-cHe-ADP ) C 085-25 5 x 5 μmol pending N6- Cyclohexyladenosine- 5'- O- triphosphate ( 6-cHe-ATP ) C 084-05 5 μmol ~2.9 mg 206978-73-6 N6- Cyclohexyladenosine- 5'- O- triphosphate ( 6-cHe-ATP ) C 084-25 5 x 5 μmol 206978-73-6 N6- Cyclopentyladenosine- 5'- O- diphosphate ( 6-cPe-ADP ) C 061-05 5 μmol ~2.5 mg 681175-79-1 N6- Cyclopentyladenosine- 5'- O- diphosphate ( 6-cPe-ADP ) C 061-25 5 x 5 μmol 681175-79-1 N6- Cyclopentyladenosine- 5'- O- monophosphate ( 6-cPe-AMP ) C 089-05 5 μmol ~2.1 mg 117778-38-8 N6- Cyclopentyladenosine- 5'- O- monophosphate ( 6-cPe-AMP ) C 089-25 5 x 5 μmol 117778-38-8 N6- Cyclopentyladenosine- 5'- O- triphosphate ( 6-cPe-ATP ) C 062-05 5 μmol ~2.9 mg 189822-11-5 N6- Cyclopentyladenosine- 5'- O- triphosphate ( 6-cPe-ATP ) C 062-25 5 x 5 μmol 189822-11-5 N6- Furfuryladenosine- 5'- O- (3- thiotriphosphate) ( 6-Fu-ATP-gamma-S ), sodium salt F 008-05 5 μmol ~3 mg pending N6- Furfuryladenosine- 5'- O- (3- thiotriphosphate) ( 6-Fu-ATP-gamma-S ), sodium salt F 008-25 5 x 5 μmol pending N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ), sodium salt F 006-05 5 μmol ~2.5 mg pending N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ), sodium salt F 006-25 5 x 5 μmol pending N6- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP ), sodium salt F 007-05 5 μmol ~2.9 mg pending N6- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP ), sodium salt F 007-25 5 x 5 μmol pending N6- Methyladenosine- 5'- O- monophosphate ( N6-5'-Me-AMP ) M 038-10 10 μmol ~3.6 mg 81921-35-9 N6- Methyladenosine- 5'- O- monophosphate ( N6-5'-Me-AMP ) M 038-50 5 x 10 μmol 81921-35-9 N6- Mono- tert. butylcarbamoyladenosine- 3', 5'- cyclic monophosphate ( 6-MBC-cAMP ) M 012-05 5 μmol ~2.3 mg 84433-46-5 N6- Mono- tert. butylcarbamoyladenosine- 3', 5'- cyclic monophosphate ( 6-MBC-cAMP ) M 012-25 5 x 5 μmol 84433-46-5 N6- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 6-MB-cAMP ) M 003-250 5 x 50 μmol 70253-67-7 N6- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 6-MB-cAMP ) M 003-50 50 μmol ~21 mg 70253-67-7 N6- Phenyladenosine- 3', 5'- cyclic monophosphate ( 6-Phe-cAMP ) P 006-05 5 μmol ~2.1 mg 34051-30-4 N6- Phenyladenosine- 3', 5'- cyclic monophosphate ( 6-Phe-cAMP ) P 006-25 5 x 5 μmol 34051-30-4 N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Phe-cAMPS ) P 018-05 5 μmol ~2.2 mg 169335-92-6 N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Phe-cAMPS ) P 018-25 5 x 5 μmol 169335-92-6 N6- Phenyladenosine- 5'- O- diphosphate ( 6-Phe-ADP ) P 014-05 5 μmol ~2.5 mg 105701-92-6 N6- Phenyladenosine- 5'- O- diphosphate ( 6-Phe-ADP ) P 014-25 5 x 5 μmol 105701-92-6 N6- Phenyladenosine- 5'- O- triphosphate ( 6-Phe-ATP ) P 015-05 5 μmol ~2.9 mg 105740-47-4 N6- Phenyladenosine- 5'- O- triphosphate ( 6-Phe-ATP ) P 015-25 5 x 5 μmol 105740-47-4 N6-(2- Phenylethyl)adenosine- 5'- O- diphosphate ( 6-PhEt-ADP ) P 013-05 5 μmol ~2.7 mg 681175-76-8 N6-(2- Phenylethyl)adenosine- 5'- O- diphosphate ( 6-PhEt-ADP ) P 013-25 5 x 5 μmol 681175-76-8 N6-(2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ) P 012-05 5 μmol ~3.1 mg 181705-62-4 N6-(2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ) P 012-25 5 x 5 μmol 181705-62-4 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), economy grade D 009-250 E 5 x 50 mg 16980-89-5 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), economy grade D 009-50 E 50 mg ~102 μmol 16980-89-5 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), high purity grade D 009-100 100 μmol ~49 mg 16980-89-5 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), high purity grade D 009-500 5 x 100 μmol 16980-89-5 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( DB-cAMP-AM ) D 008-01 1 μmol ~0.5 mg 159910-48-2 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( DB-cAMP-AM ) D 008-05 5 x 1 μmol 159910-48-2 P1- (5'- Adenosyl)- P4- (5'- uridyl)- tetraphosphate / Uridine- adenosine- 5'- tetraphosphate ( Up4A ) U 008-01 1 μmol ~0.8 mg 10527-48-7 P1- (5'- Adenosyl)- P4- (5'- uridyl)- tetraphosphate / Uridine- adenosine- 5'- tetraphosphate ( Up4A ) U 008-05 5 x 1 μmol 10527-48-7 PKG inhibitor peptide DT-2 D 051-005 0.5 mg ~0.14 μmol pending PKG inhibitor peptide DT-2 D 051-025 5 x 0.5 mg pending PKG inhibitor peptide DT-3 D 052-005 0.5 mg ~0.16 μmol pending PKG inhibitor peptide DT-3 D 052-025 5 x 0.5 mg pending Purine riboside- 3', 5'- cyclic monophosphate ( cPuMP ) P 010-05 5 μmol ~1.7 mg 53303-84-7 Purine riboside- 3', 5'- cyclic monophosphate ( cPuMP ) P 010-25 5 x 5 μmol 53303-84-7 Purine riboside- 5'- O- monophosphate ( 5'-PuMP ) P 011-05 5 μmol ~1.6 mg 13484-60-1 Purine riboside- 5'- O- monophosphate ( 5'-PuMP ) P 011-25 5 x 5 μmol 13484-60-1 Purine riboside- 5'- O- triphosphate ( PuTP ) P 009-05 5 μmol ~2.5 mg 23197-96-8 Purine riboside- 5'- O- triphosphate ( PuTP ) P 009-25 5 x 5 μmol 23197-96-8 Thymidine- 3', 5'- cyclic monophosphate ( cTMP ) T 005-05 5 μmol ~1.6 mg 76567-90-3 Thymidine- 3', 5'- cyclic monophosphate ( cTMP ) T 005-25 5 x 5 μmol 76567-90-3 Thymidine- 3', 5'- O- bisphosphate ( pTp ) / 2'- Deoxythymidine- 3', 5'- O- bisphosphate T 012-05 5 μmol ~2 mg [2863-04-9] Thymidine- 3', 5'- O- bisphosphate ( pTp ) / 2'- Deoxythymidine- 3', 5'- O- bisphosphate T 012-25 5 x 5 μmol [2863-04-9] Thymidine- 5'- O- (1-thiotriphosphate), Rp-isomer ( Rp-TTP-α-S ) T 002-05 5 μmol ~2.5 mg 83199-35-3 Thymidine- 5'- O- (1-thiotriphosphate), Rp-isomer ( Rp-TTP-α-S ) T 002-25 5 x 5 μmol 83199-35-3 Thymidine- 5'- O- (1-thiotriphosphate), Sp-isomer ( Sp-TTP-α-S ) T 003-05 5 μmol ~2.5 mg 83199-32-0 Thymidine- 5'- O- (1-thiotriphosphate), Sp-isomer ( Sp-TTP-α-S ) T 003-25 5 x 5 μmol 83199-32-0 Thymidine- 5'- O- (α, β- methylene)diphosphate ( TMP-CP ) T 008-05 5 μmol ~2 mg 55065-40-2 Thymidine- 5'- O- (α, β- methylene)diphosphate ( TMP-CP ) T 008-25 5 x 5 μmol 55065-40-2 Thymidine- 5'- O- monophosphorothioate ( 5'-TMPS ) T 004-05 5 μmol ~1.6 mg 15548-51-3 Thymidine- 5'- O- monophosphorothioate ( 5'-TMPS ) T 004-25 5 x 5 μmol 15548-51-3 Uridine- 2', 3'- cyclic monophosphate ( 2',3'-cUMP ) U 004-250 5 x 50 μmol 15718-50-0 Uridine- 2', 3'- cyclic monophosphate ( 2',3'-cUMP ) U 004-50 50 μmol ~16 mg 15718-50-0 Uridine- 3', 5'- cyclic monophosphate ( cUMP ) U 001-250 5 x 50 μmol 56632-58-7 Uridine- 3', 5'- cyclic monophosphate ( cUMP ) U 001-50 50 μmol ~16 mg 56632-58-7 Uridine- 5'- O- (1-thiotriphosphate), Rp- isomer ( Rp-UTP-α-S ) U 002-05 5 μmol ~2.5 mg 71214-30-4 Uridine- 5'- O- (1-thiotriphosphate), Rp- isomer ( Rp-UTP-α-S ) U 002-25 5 x 5 μmol 71214-30-4 Uridine- 5'- O- (1-thiotriphosphate), Sp- isomer ( Sp-UTP-α-S ) U 003-05 5 μmol ~2.5 mg 71214-29-4 Uridine- 5'- O- (1-thiotriphosphate), Sp- isomer ( Sp-UTP-α-S ) U 003-25 5 x 5 μmol 71214-29-4 Uridine- 5'- O- (3- thiotriphosphate) ( UTP-gamma-S ), sodium salt U 010-05 5 μmol ~2.5 mg 79049-97-1 Uridine- 5'- O- (3- thiotriphosphate) ( UTP-gamma-S ), sodium salt U 010-25 5 x 5 μmol 79049-97-1 Uridine- 5'- O- (α, β- methylenediphosphate) ( UMP-CP ) U 009-05 5 μmol ~2 mg 732921-73-2 Uridine- 5'- O- (α, β- methylenediphosphate) ( UMP-CP ) U 009-25 5 x 5 μmol 732921-73-2 Uridine- 5'- O- monophosphorothioate ( 5'-UMPS ) U 006-05 5 μmol ~1.7 mg 15548-52-4 Uridine- 5'- O- monophosphorothioate ( 5'-UMPS ) U 006-25 5 x 5 μmol 15548-52-4 Xanthosine- 3', 5'- cyclic monophosphate ( cXMP ) X 001-05 5 μmol ~1.8 mg 31319-70-7 Xanthosine- 3', 5'- cyclic monophosphate ( cXMP ) X 001-25 5 x 5 μmol 31319-70-7